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ABSTRACT 
Genome engineering is the intentional alteration of the genetic information in living 
cells or organisms.  Since Clustered Regularly Interspaced Short Palindromic 
Repeat/CRISPR-associated 9 (CRISPR/Cas9) was repurposed for genome engineering, 
the “CRISPR Craze” is quickly bridging the genotype and phenotype worlds and 
transforming the biological, biomedical and biotechnological research.  Interestingly, 
CRISRP/Cas9 does not perform precise genome engineering (PGE) by itself, but it only 
induces a targeted genomic lesion and invites the HDR pathways to introduce the 
desired modifications.  Although PGE has a wide application in genome modification and 
gene therapy, the identity, property and hierarchy of the HDR pathways leading to the 
formation of PGE products remain obscure. 
In my doctorial dissertation, I demonstrated that double-strand DNA (dsDNA) 
donors with a sizable central heterology preferentially utilize the double-strand break 
repair (DSBR) pathway in the absence and presence of chromosomal double-strand 
breaks (DSBs).  This pathway generates long, bidirectional conversion tracts with linear 
distribution.  In contrast, single-strand oligonucleotide (ODN) donors utilize the 
synthesis-dependent strand annealing (SDSA) and single-strand DNA incorporation 
(ssDI) pathways, respectively, depending on the strandedness of the genomic lesions 
and ODN donors.  These pathways produce short, unidirectional and bidirectional 
conversion tracts with Gaussian distributions.  The SDSA pathway is preferentially 
utilized in the presence of compound genomic lesions such as DSBs and paired nicks.  
In summary, this work systematically determined the identity, property and hierarchy of 
the HDR pathways underlying PGE with definitive molecular evidence, and provided 
practical guidelines for the improvement of PGE.  
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CHAPTER I: INTRODUCTION 
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Background 
All the genetic information (i.e. the genome) of a cellular organism is stored in the 
form of DNA [1].  Human somatic cells carry about 3.2 billion base pairs of DNA 
arranged in 23 pairs of enormously long molecules called chromosomes.  These 
chromosomes contain a total of approximately 20,000 molecular units (i.e. genes), which 
encode proteins and catalytic RNAs that substantiate the vast majority of cellular 
functions, such as metabolism, signaling, maintenance and proliferation.  Furthermore, 
the functions of about 3.7 X 1013 cells in our body [2] are collaborated to support the 
daily activities of our living including perception, cogitation, motion and reading this 
dissertation. 
The faithful maintenance and transmission of genetic information is crucial to all 
forms of cellular and organismal lives.   However, genomic lesions can arise from errors 
of endogenous DNA replication and exposure to exogenous DNA damaging agents.  
DSBs are the most lethal forms of genomic lesions to living cells.  DSBs occur about 10 
times per cell per day, and a single unrepaired DSB may lead to cell death [3].  
Moreover, the improper repair of DSBs may lead to mutagenesis and tumorigenesis [4, 
5].  Eukaryotes have developed two major pathways of DSB repair: HDR and non-
homologous end joining (NHEJ).  HDR precisely repairs DSBs using the redundancy of 
genetic information on the homology donors [6, 7]; whereas NHEJ efficiently joins DNA 
ends together after minimal necessary processing [8-10].   
For the first time, genome engineering allows human beings to intentionally 
manipulate the hereditary materials of living organisms that are otherwise only 
accessible to natural evolution.  Although cumbersome in the beginning, the 
development of artificial meganucleases, especially CRISPR/Cas9, dramatically 
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accelerated the process of genome manipulation.  Nowadays, plants and animals with 
desired genotypes can be produced in laboratories within one life cycle of these model 
organisms, which greatly facilitate the deciphering of the astronomic amount of genetic 
information generated by the genome sequencing projects.  In clinics, gene therapies 
are in various stages of human trials [11], which hold the promise of permanently 
treating inherited diseases and incurable viruses.  Interestingly, meganucleases do not 
perform genome engineering by themselves, but they induce targeted genomic lesions 
and facilitate either high-efficiency gene disruption via NHEJ or, in the presence of 
homology donors, PGE via the HDR pathways [12].  Although PGE generates precisely 
predictable outcomes, its efficiency largely depends on the HDR machinery and cell 
cycle status of the specific organisms.  Importantly, the mechanisms and characteristics 
of the HDR pathways leading to PGE are not well understood in human cells. 
In this dissertation, Chapter I contains a comprehensive introduction of the DNA 
DSB repair pathways and the development of PGE technologies.  In Chapter II and 
chapter III, the molecular mechanisms of PGE in human cells using dsDNA and ODN 
donors are dissected with definitive experimental evidence.  In Chapter IV, the 
significance of this study and the prospects of PGE are discussed.  
  
  4 
DNA Double-Strand Break Repair 
 
“We totally missed the possible role of … (DNA) repair although … I 
later came to realise that DNA is so precious that probably many 
distinct repair mechanisms would exist.” 
 Francis Crick wrote in Nature, 1974 [13] 
Homology-directed repair 
HDR, aka homologous recombination, is the exchange of genetic information 
between similar or identical sequences.  It is an accurate way of repairing DNA DSBs 
using the redundancy of genetic information on the homology donors, such as the 
undamaged sister chromatids or homologous chromosomes.  In budding yeast 
Saccharomyces cerevisiae, HDR repairs the bulk of ionizing radiation (IR)-induced DSB, 
whereas NHEJ simply fails to do so for the lack of end processing enzymes [14].  In 
mammalian cells, in contrast, HDR plays a minor role in DSB repair due to the robust 
competition from non-homologous end joining (NHEJ) [15].  HDR repairs a fraction of 
DSBs mainly in the S and, to a lesser extent, in the G2/M phases of the cell cycle [16].  It 
is also involved in repairing complex genomic lesions such as Holliday junctions (HJs), 
interstrand crosslinks (ICLs) and stalled replication forks (SRFs).  Besides DNA repair 
and replication, HDR is also required for the meiotic segregation and telomere 
maintenance [6].  Furthermore, the dysfunction of HDR is associated with cancer pre-
deposition [4, 5] and aging [17].   
The genetic players in the HDR pathways can be easily identified in yeast as 
mutants sensitive to IR [18].  Because the yeast RAD52 is required in all the HDR 
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pathways, most of these HDR mutants fall into the RAD52 epistasis group [19, 20], 
which currently includes: RAD50, RAD51, RAD52, RAD53, RAD54, RAD55, RAD56, 
RAD57, RAD59, MRE11, XRS2 and RDH54/TID1 [6, 7, 21].  The functions of these 
genes are generally well conserved in the mammalian HDR, despite the existence of 
multiple homologs of RAD51, RAD54 and RAD55-77, and the emergence of BRCA1 and 
BRCA2 that partially replace the function of RAD52.  However, the classification of HDR 
genes into the RAD52 epistasis group masks the subdivision of this complicated 
molecular gymnastics into at least six different pathways [21] as elaborated below:  
The double-strand break repair model 
The DSBR (aka, Szostak) model was first elaborated by Szostak JW. et al. [22, 23] 
based on the conceptual contributions from Holliday R [24], Meselson MS. and Radding 
CM. [25].  In this model, as is illustrated in Figure 1A, after HDR is initiated by DSB 
formation, the 5’ ends of the DSB are processed by nucleolytic resection.  The resection 
gives rise to free single-strand 3’ ends, and one of them invades a double-strand 
homology donor during homology search.  DNA synthesis then extends the invading 3’ 
end using the donor sequence as a template, and the displacement synthesis leads to 
the formation of a displacement loop (D-loop).  Importantly, the second end of the DSB 
is captured and annealed to the extending D-loop in this DSBR model, leading to the 
formation of two HJs.  The resolution of the double HJs by resolvases generates both 
crossover and non-crossover products. 
The DSBR model is characterized by the generation of equal amounts of crossover 
and non-crossover products.  Moreover, one of the non-crossover products contains the 
signature bidirectional conversion tract in respect to the DSB.  In addition, as is 
  6 
elaborated in Chapter II, this dissertation also revealed a novel molecular feature of the 
DSBR pathway, which is long-tract gene conversion. 
Holliday junction dissolution 
Although the crossovers generated by the DSBR pathway are required for the 
proper segregation of chromosomes during meiosis, they may cause deleterious 
mutations and are thus suppressed in mitotic cells.  The HJ dissolution pathway 
emerges as an alternative way of solving double HJ structures, in which the HJs cancel 
out each other as a result of inward branch migrations catalyzed by a HJ dissolution 
complex composed of BLM, TopoIIIα, RMI1 and RMI2 [26-28].    As is illustrated in 
Figure 1B, this pathway is identical to DSBR till the second strand capture step.  Then 
branch migration occurs and, instead of resolved by the endonuclease cleavage, the 
HJs simply cancel out each other in the help of the BLM complex. 
Because the invading strand eventually anneals back with its original partner, gene 
conversion stems from the unidirectional DNA synthesis using the homology donor as a 
template.  As a result, this pathway only generates non-crossover products.  Since a 
large D-loop can be stabilized by second strand capture, we reason that HJ dissolution 
is also a long-tract gene conversion pathway similar to DSBR. 
Synthesis-dependent strand annealing 
The DSBR model was originally proposed according to the observations of the 
meiotic recombination in yeast.  However, mitotic recombination is infrequently 
associated with crossovers in yeast, fruit flies and mammalian cells [29-32].  In addition, 
DSB-induced gene conversion in mouse and human cells predominantly produces short 
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unidirectional conversion tracts [33].  These observations leads to the proposition of 
SDSA as the major pathway of HDR-mediated DSB repair in mitotic cells [6, 7, 21]. 
The SDSA pathway, as is illustrated in Figure 1C, is similar to the DSBR model till 
displacement synthesis.  After the D-loop formation, in contrast, the synapse collapse 
before the second end capture, and the invading strand anneals back with the second 
end of the homology recipient on the other side of the DSB.  Similar to the HJ dissolution 
pathway, the donor sequence is converted unidirectionally as a result of DNA synthesis, 
and this pathway produces only non-crossover products.  However, as is demonstrated 
in Chapter III and another publication [33], SDSA is a short-tract gene conversion 
pathway that may result in the loss-of-heterozygosity (LOH) in DSB repair. 
Break-induced replication 
Early studies of DSB-induced gene conversion revealed a unidirectional Bi-
Gaussian distribution of the conversion tracts in yeast, mouse and human cells [33, 34].  
The generation of ultra long conversion tracts suggested the existence of an alternative 
HDR pathway that was later proved to be BIR [35, 36].  In this pathway, as is illustrated 
in Figure 1D, the second end of the DSB is either lost or non-existent (such as collapsed 
replication forks or telomeric DSBs).  Thus the invading end has to perform long-tract 
displacement synthesis until it travels through the rest of the template chromosome or 
encounters a converging replication fork [36].  Then a complementary single-strand DNA 
primer fills in to initiate the reverse synthesis similar, but not exactly the same, to the 
lagging strand synthesis in a replication fork. 
Because the entire chromosome on the other side of the DSB has to be 
reconstituted via DNA synthesis, BIR can lead to long-tract LOH in the chromosomal 
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scale.  Also, the template switching process can be highly mutagenic.  As a result, this 
pathway is usually suppressed in the presence of the second end [35]. 
Single-strand annealing 
Occasionally, DSBs occur in between direct repeats such as microsatellites 
sequences, which allow the self-templated repair via a homology-directed deletion 
process called SSA.  In this pathway, as is illustrated in Figure 1E, the DNA ends are 
resected to reveal complementary single-strand 3’ overhangs that are subsequently 
annealed together to bridge the DSBs.  This pathway results in the deletion of the non-
homology sequence in between the direct repeats as well as one copy of the repeats.  
The strand annealing process requires the activity of RAD52 in yeast, but is independent 
of strand invasion and HJ formations in the DSBR pathway [7, 37].  
Single-strand DNA incorporation 
Unlike all the HDR pathways mentioned above, ssDI (aka, single-strand 
assimilation) is not generally regarded as an endogenous DNA repair process.  However, 
it is widely used in the PGE field to describe the incorporation of exogenous single-
strand DNA, including ODNs [38-40] and recombinant adeno-associated virus (rAAV) 
[41-43] donors, into genomic lesions such as DSBs.  Although this pathway occurs at a 
relatively low frequency, its existence was confirmed by the physical incorporation of 
ODNs into the targeted chromosome locus in the absence of exogenous genomic 
lesions [38].  Interestingly, a variation of this pathway can also occur via a single-strand 
RNA intermediate, in which the transcript RNA bridges one strand of the DSB without 
being physically incorporated into the genome [44]. 
  9 
In the ssDI pathway, as is illustrated in Figure 1F, a single-strand DNA or RNA 
donor is assimilated to a single-strand gap via homology base-paring with the 
complementary strand.  After the displacement of the flanking homology sequences via 
branch migration like activities, the DNA flaps are cleaved by endonucleases and part of 
the donor sequence is physically ligated into the chromosome to bridge the single-strand 
gap.  If the gap is generated by DSBs, the resulting nick on the other strand is further 
repaired by standard single-strand break repair.  The ssDI pathway is characterized by 
the bidirectional gene conversion and the physical incorporation of the donor sequence 
into chromosomes [38].  It was also demonstrates that ssDI is a short-tract gene 
conversion pathway in Chapter III of this dissertation. 
Non-homologous end joining 
NHEJ is the major pathway of repairing IR-induced DSBs in human cells.  NHEJ 
has robust DSB repair activity in all phases of the cell cycle, which increases as cells 
progress from the G1 to the G2/M phases [16].  NHEJ is also required for the repair of 
programmed DSBs during V(D)J recombination in lymphocytes maturation [15, 45, 46].  
In addition, evidence suggests that NHEJ is the major source of chromosomal 
translocations during cancer development [47, 48].   
Unlike HDR, the NHEJ pathways do not require extended homology in repairing 
DSBs.  Instead, the NHEJ proteins bind to the broken DNA ends, and ligate them 
together after minimal necessary processing.  Depending on the extent or arguably the 
property of the microhomology being utilized, the NHEJ pathways can be divided into 
canonical NHEJ (C-NHEJ) and alternative NHEJ (A-NHEJ).  These pathways seem to 
utilize different panels of protein players, although the specific molecular distinctions 
remain controversial [9].  
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Precise Genome Engineering 
 
“(CRISPR/Cas9) is really a triumph of basic science and in many ways 
it’s better than RNA interference. It’s a tremendous breakthrough with 
huge implications for molecular genetics. It’s a real game-changer.” 
Craig Mello told The Independence, 2013 [49] 
A brief history of genome engineering 
Genome engineering is the intentional alteration of a genetic locus in living cells or 
organisms.  According to the purpose of engineering, it can be classified into genetic 
knock-out and genetic knock-in.  Genetic knock-out is the targeted inactivation of an 
endogenous gene, whereas genetic knock-in is the introduction of a desired modification 
into a designated genetic locus.  Both of these approaches take advantage of the 
endogenous DNA DSB repair processes.  According to the specific DNA repair pathway 
being utilized, genome engineering can be divided into the NHEJ-mediated gene 
disruption, and the HDR-mediated PGE. 
PGE precisely convert the genetic information from exogenous homology donors to 
a targeted locus on the chromosome via the HDR pathways.  Notably, this approach can 
be applied to both genetic knock-out and genetic knock-in.  Since PGE generates 
precisely predictable outcomes in the conversion products, it represents the more 
desirable pathway of genome engineering and holds promise for correction-based gene 
therapy.  However, because of the limited HDR activity in the somatic cells of higher 
eukaryotes [8, 16], the efficiency of spontaneous PGE (i.e., PGE in the absence of 
  11 
targeted genomic lesions) is relatively low and highly variable depending on the cell 
cycle status and the specific research model being used [50]. 
Interestingly, the efficiency of PGE can be stimulated by more than 1,000 fold in the 
presence of targeted genomic lesions near the target locus, such as DSBs created by 
meganucleases [51-53].  This observation started a new era of PGE using artificial 
meganucleases (aka, designer or programmable meganucleases).  Zinc finger 
nucleases (ZFNs) [54], transcription activator-like effector nucleases (TALENs) [55] and 
CRISPR/Cas9 [56-60] were sequentially developed such that targeted genomic lesions 
could be introduced with increasing ease.  Unlike natural meganucleases, the artificial 
meganucleases can be engineered to bind to, in principle, any designated sequences in 
the genome, which obviates the need of knocking in their recognition sites near the 
target locus, ironically via PGE itself.  After DNA recognition, the meganucleases create 
genomic lesions and facilitate high-efficiency gene disruption via NHEJ, or PGE via the 
HDR pathways in the presence of exogenous homology donors [12].  In general, these 
homology donors can be classified into dsDNA (including plasmid vectors and viruses 
with dsDNA intermediates), rAAV and ODNs. 
Homology donors 
Double-strand DNA donors 
To the best of my knowledge, the first PGE experiment in eukaryotic cells was 
carried out by Hinnen A. et al in 1987 [61].  As a corollary discovery of the Calcium 
chloride transformation method in yeast [61], it was discovered that a large fraction of 
the transformed plasmids were precisely targeted into the homologous chromosomal 
locus when circular plasmids with homology region were utilized [62].  However, this 
PGE technology did not become popular until Rothstein R. and collaborators 
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demonstrated that its frequency can be dramatically increased by linearizing the plasmid 
at both ends of the homology regions [63].  These findings also led to the development 
of the DSBR model of homologous recombination [22, 23], which was later proved to be 
the major mechanism of mitotic HDR and PGE in yeast [64].  The idea of PGE using 
linear dsDNA donors via the spontaneous “ends-out” recombination was later extended 
to the genetic knock-outs and knock-ins in mammalian cells and won Smithies O. and 
Capecchi MR. the Nobel Prize in 2007 [65, 66].  In a standard dsDNA donor, the knock-
in mutation is flanked by long homology arms ranging from 0.8-12 kb. 
Recombinant adeno-associated virus donors 
Although spontaneous PGE using dsDNA donors works relatively well in yeasts, 
flies and murine embryonic stem cells, its efficiency drops to as low as 10-6 in human 
cells due to the weak HDR activity and the robust competing pathway of C-NHEJ.  
Isolating the rare PGE products thus requires the laborious screening of thousands of 
individual subclones even in the presence of drug selection [67-69].  Importantly, Russell 
DW. and coworkers reported that the efficiency of spontaneous PGE could be increased 
up to 3 orders of magnitude by the use of rAAV donors [70].  The use of rAAV donors 
along with the development of advanced promoter trapping strategies collaboratively 
increased the efficiency of PGE to a comfortable range in human cells [71].  
Adeno-associated virus is a single-strand DNA virus.  Its entire 4.7 kb genome is 
composed of two viral genes flanked by structural elements called inverted terminal 
repeats.  Because of its low pathogenicity and immunogenicity and broad tropism in 
human and mouse cells, rAAV was widely used for delivering exogenous DNA into 
human cells for transfection and gene therapy.  However, it was not known why rAAV 
also works so well as a PGE donor.  Some papers suggested that this was because, 
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unlike dsDNA donors, rAAV-mediated PGE could utilize the ssDI pathway [41-43].  
Nevertheless, rAAV can become double-stranded during replication, and it is not known 
whether PGE is initiated by the single-stranded or double-stranded viral intermediates. 
Single-strand oligonucleotide donors 
ODNs cannot initiate efficient PGE in the absence of meganucleases because they 
have to engage endogenously occurring genomic lesions.  It was proposed that ODNs 
could be incorporated into the gaps generated by nucleotide excision repair [72, 73] or 
the lagging strand synthesis during DNA replication [74-76], although the specific 
mechanisms are still disputed [77, 78].  Notably, both of these models involve the 
physical assimilation of the ODNs into the genome via an ssDI-like mechanism. 
Interestingly, ODNs are much more potent PGE donors in the presence of targeted 
genomic lesions induced by meganucleases [79], probably due to the use of an 
alternative pathway other than ssDI.  Consistent with this notion, it was demonstrated 
that the ODN donors were physically incorporated into the genome in the absence, but 
not presence, of meganucleases [38, 79].   Because ODN donors can be easily 
chemically synthesized, they are widely used in conjunction with ZFNs, TALENs and 
CRISPR/Cas9.  Unlike dsDNA donors, ODN can also mediate efficient PGE in the 
presence of targeted single-strand nicks.  It was proposed that nick-induced PGE using 
ODN donors utilizes certain forms of the SDSA and the ssDI pathways depending on the 
relative strandedness of the ODN donors and the nick [40, 80].  However, the exact 
mechanisms of ODN-mediated PGE remained elusive. 
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Artificial meganucleases 
Meganucleases are endonucleases with a large recognition site, which, in principle, 
does not occur naturally in a given genome.  They can be used to introduce targeted 
lesions (such as DSBs) in the genome and dramatically enhance the efficiency of PGE 
using all kinds of donors [51, 52, 79].  Natural meganucleases (aka, homing 
endonucleases) such as I-SceI and I-AniI are the first generation of meganucleases 
used in PGE [81, 82].  Due to the extremely low programmability, ironically, their 
recognition sites have to be pre-engineered into the genome before they can be used to 
induce PGE.  Thus the application of natural meganucleases in PGE is mainly limited to 
proof-of-principle experiments and mechanistic studies. 
Zinc finger nucleases 
To increase the programmability of meganucleases, Chandrasegaran and 
colleagues fused the catalytic domain of a Type IIs restriction enzyme FokI to the zinc 
finger DNA recognition domains (ZFs), and demonstrated that the specificity of the FokI 
catalytic domain could be completely dictated by the ZF arrays [54].  ZFs are modular 
DNA binding domains originally identified in the sequence-specific transcription factors 
[83] of eukaryotic cells.  Each ZF binds to approximately 3 bp of double-strand DNA, and 
multiple modules can be combined to recognize a wide range of unique target 
sequences in the genome.  By fusing the designated ZF arrays to the catalytic domain of 
FokI, the resultant ZFN can be programmed to cut almost any specific region in the 
genome.  Also, the individual FokI monomers can be targeted to the adjacent regions of 
the genome by different ZF arrays to increase the specificity of the resultant ZFNs [84]. 
However, because the binding affinity and specificity of ZFNs are dependent on 
both the individual ZFs and their context, the activity and specificity of ZFNs are 
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generally lower than the later generations of artificial meganucleases [12, 85].  Also, 
since each individual ZF recognizes a tri-nucleotide codon, a large ZF library has to be 
kept in order to routinely create the custom ZF arrays and target random sequences in 
the genome.  Thus the application of ZFNs is mainly limited to experienced laboratories 
and companies, and the cost remains high despite the effort of streamlined production. 
Transcription activator-like effector nucleases 
Plant pathogens such as Xanthomonas encode transcription activator-like effectors 
(TALEs) that can specifically up-regulate the host genes to promote infectivity.  The DNA 
binding domains of TALEs are composed of tandem repeats of ~34 amino acids, and 
each module of the repeats recognizes a single base pair of double-strand DNA [86].  
The DNA binding specificity of these modules are completely determined by 2 variable 
amino acid residues in the 12-13 position, which is named repeat variable diresidues 
(RVDs), whereas the backbone sequences of these modules are conserved.  
Interestingly, the TALE modules can be reprogrammed to bind almost any designated 
sequences in the genome, although certain restrictions may apply [12]. 
When a designer TALE domain is fused to the catalytic domain of FokI, it can direct 
the non-specific nuclease to cut designated sequences in the genome [55].  Because the 
DNA binding modules have a 1:1 correspondence with the target nucleotide sequences, 
the generation of custom designed TALENs requires a much smaller library of DNA 
binding modules than ZFNs.  Also, the Golden Gate ligation has been adapted to the 
cloning of DNA binding modules into TALEN, which dramatically reduce the time cost of 
TALEN assembly [87].  As a result, TALENs are widely used in medium-sized 
laboratories and companies for genome engineering. 
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Clustered regularly interspaced short palindromic repeat/CRISPR-associated 9 
Although the assembly of ZFNs and TALENs can be somehow streamlined, it still 
requires the de novo assembly of large DNA binding domains.  The CRISPR/Cas9 
system circumvents this requirement because the specificity of Cas9 is completely 
dictated by a 20 bp sequence on the CRISPR RNA (crRNA) complementary to the 
protospacer.  This feature of CRISPR/Cas9 obviates the requirement of protein 
engineering and leads to the era of RNA-guided genome engineering. 
CRISPR/Cas9 was originally identified as an adaptive immune system in bacteria 
and archaea [88].  These microbes capture short DNA fragments from invading 
(defective) phages and integrate them as protospacers into the CRISPR locus into their 
genomes as immunological memory [89].  When these microbes are intruded by phages 
containing similar protospacers again, the invading genomes can be specifically cleaved 
by the Cas9 complex in an RNA-dependent manner.  The Type II CRISPR system is 
most frequently used in genome engineering because it contains only one protein (Cas9) 
and two RNA components (crRNA and trans-activating crRNA, i.e., tracrRNA) [56].  
Cas9 first binds to the crRNA and tracrRNA before it is recruited onto the genome 
depending on the density of the protospacer-adjacent motif (PAM).  The PAM is a short 
sequence motif (e.g. NGG for the Cas9 from S. pyogenes) located in the vicinity of the 
protospacer in the invading genomes but not the CRISPR arrays of the host genomes.  It 
plays an important role in distinguishing between “self” and “non-self” during Cas9-
mediated cleavage [90].  After the recruitment of the Cas9 complex, it opens up the DNA 
double-helix and establishes base-paring between the crRNA and the putative 
protospacer sequence, resulting in the formation of a D-loop.  Mismatches between the 
crRNA and the seed sequence (the 8-13 bp PAM proximal sequence) typically leads to 
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D-loop rejection, although mismatches in the PAM distal region may be better tolerated 
[91, 92].  When the D-loop is allowed to mature, however, it triggers a conformational 
change of Cas9 to cleave the protospacer sequence approximately 3 bp upstream of the 
PAM [93].  Interestingly, these two RNA components of the Cas9 complex can be 
combined into a short guide RNA (sgRNA), which further simplifies the CRISPR/Cas9 
system [56].  The Cas9/sgRNA complex can be targeted to anywhere in the genome by 
reprogramming the 20 bp protospacer on the RNA component, obviating the need of 
complicated protein engineering.  As a result, the sheer simplicity and user-friendliness 
of the CRSIRP/Cas9 system makes it a game-changer of genome engineering and gives 
birth to the “CRISPR Craze”. 
The “CRISPR Craze” 
Since CRISPR/Cas9 was repurposed for genome engineering in the beginning of 
2013 [57-60], more than 1500 papers have been published in the last 2.5 years, 
documenting the application of this technology in biological, biomedical and 
biotechnological studies [94-99].  As for genome engineering, the “CRISPR speed” is 
quickly bridging the genotype and phenotype worlds and facilitating the generation of 
genetically modified research models within a single life cycle of the specific host 
organisms [100-103].  In addition, the facile adaptation of this technology via the codon 
optimization of Cas9 is quickly increasing the list of genome-tractable organisms [12].  
Beside genome engineering, a wide range of tools have been created for targeted 
transcriptional activation/suppression [104, 105], epigenetic regulations [106], 
chromosomal gymnastics [94] and live imaging [107] by fusing a catalytically dead Cas9 
to other functional domains.  These tools are widely used in genomic screening [108, 
109], genetic testing [110], metabolic engineering [95, 111], synthetic biology [112, 113], 
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pathogen elimination [114, 115], gene drive [115, 116], drug identification [109, 117] and 
human gene therapy [118, 119].  As for now, the list of publications with CRISPR/Cas9 
is growing in an exponential manner, as the “CRISPR Craze” continues.  Scientists are 
already starting to compare CRISPR/Cas9 to the most influential fundamental 
technological platforms such as RNA interference (RNAi), induced pluripotent stem cells 
(iPS cells), polymerase chain reaction (PCR)…, and probably even beyond [49, 97, 99]. 
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Figures and Legends  
 
Figure 1.  The molecular mechanism of the HDR pathways  
(A-F) Schematic illustration of the mechanism of DSBR (A), HJ dissolution (B), 
SDSA (C), BIR (D), SSA (E) and ssDI (F).  Schematic elements are colored as follows: 
recipient genomic DNA, black; genomic lesions, orange; homology donor, red; DNA 
synthesis, dashed lines; HJ resolvase cleavages, white arrows; branch migration, grey 
arrows; exonuclease resection, yellow pacmenTM; flap-/mega- endonuclease cleavage, 
yellow lightning bolts.  
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Figure 1A-B 
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Figure 1C-D 
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Figure 1E-F 
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CHAPTER II: THE MECHANISM OF PRECISE GENOME 
ENGINEERING USING dsDNA DONORS 
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Summary 
PGE in human somatic cells is of importance because it can be used to either 
delineate the loss-of-function phenotype of a gene or introduce designer modifications to 
the genome.  Both of these outcomes require a form of DNA DSB repair known as HDR.  
The mechanism of HDR leading to PGE, however, is not well understood in human cells.   
Here, we surprisingly demonstrate that the normally single-stranded rAAV performs 
PGE via double-stranded intermediates, which are mechanistically indistinguishable 
from dsDNA donors with central heterology.  Using these dsDNA donors, the canonical 
two-end, ends-out HDR intermediate in yeast is also valid for human cells.  Furthermore, 
the resolution step of this intermediate occurs via the classic DSBR model of HDR, 
whereas SDSA and Holliday junction (HJ) dissolution are, at best, minor pathways.  
Moreover, this DSBR pathway produces long bidirectional conversion tracts with linear 
distribution, which suggests that the positions of HJ resolution are evenly distributed 
along the homology arms.  Most unexpectedly, we demonstrate that when a 
meganuclease is used to introduce a chromosomal DSB at the target site, the 
mechanism of PGE is inverted such that the chromosome becomes the “attacker” 
instead of the “attackee”.   These observations significantly advance our understanding 
of HDR and PGE using dsDNA donors in human cells, and should readily lend 
themselves to developing improvements to existing methodologies 
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Introduction 
PGE is the intentionally alteration of the genetic information in living cells or 
organisms [120].  This technology has at least two applications of significant importance.  
One application is the inactivation of genes (“knockouts”), a process in which the two 
wild-type alleles of a gene are disrupted to determine the loss-of-function phenotype 
associated with that particular gene.  The second application is the introduction of 
designer modifications to the genome (“knock-ins”), including the clinically-relevant 
process of gene therapy, which in a strict sense, involves correcting a preexisting 
mutated allele of a gene back to wild-type  to alleviate the pathological phenotype 
associated with the mutation.    Importantly, although these two processes are 
conceptually reciprocal opposites of each other, they are mechanistically identical 
because both require a form of DNA DSB repair termed HDR. 
During HDR, as elaborated predominately in yeast [20], the ends of the invading 
double-stranded DNA are resected to yield 3’-ssDNA overhangs [14], which, in turn, are 
substrates for Rad51.  Rad51 is a strand exchange protein [121], which facilitates the 
base pairing of the invading strand with its homologous chromosomal donor.  After 
second strand capture, a recombination intermediate is generated with two HJs that is 
identical to the intermediate of dsDNA-mediated PGE that has been well-defined in 
yeast [20, 64, 122, 123].  Resolution of this intermediate requires different combinations 
of polymerases, helicases, nucleases and ligases that result in distinct recombination 
products.   Importantly, human cells express all of the HDR genes needed to carry out 
PGE [120].  However, because of the robust competing pathway of DSB repair known as 
NHEJ [15], PGE events occur rarely in mammals [124-126].  Indeed, despite valiant 
efforts — in particular by the Baker laboratory [125, 127, 128] — the low targeting 
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efficiency of dsDNA donors has prohibited a systematic characterization of 
recombination intermediates in mammalian cells.  To gain better insight into the 
mechanism of human PGE it is crucial to establish a more vigorous PGE system. 
Russell and coworkers have demonstrated that rAAV can target the human 
genome with frequencies up to 1% [70] (Figure S1), which is 3 to 4 orders of magnitude 
higher than dsDNA-mediated PGE.  rAAV has subsequently become a powerful tool to 
engineer knockout and knock-in mutations in the human genome [120, 129].  Despite its 
utility, the mechanism of rAAV integration remains elusive although it is clear that the 
recombinant virus, which encodes no viral proteins, must utilize host DSB repair 
pathways for its integration.  Interestingly, since only single-stranded genomes can be 
packaged into virions (Figure S1), many reviews [41-43] have postulated that rAAV-
mediated PGE utilizes the ssDI pathway. 
Here we systematically analyzed the molecular features of PGE intermediates 
using rAAV and dsDNA donors.  In contrast to popular belief, we demonstrate that rAAV 
with central heterology predominantly utilizes the DSBR model of HDR [130] with 
double-stranded viral DNA utilized as a substrate.  Specifically, we analyzed the 
retention of single nucleotide polymorphisms (SNPs) — markers that allowed us to 
distinguish donor from recipient DNA — during PGE and random integration.  We show 
that, in contrast to lower eukaryotes and murine embryonic stem cells [131-134], the 
positions of HJ resolution are evenly distributed along the homology arms of the donors 
(Figure S2) in two independent human cell lines.  In addition, we demonstrate that 
rAAV-mediated PGE events are mechanistically distinguishable from random integration 
events.  Most unexpectedly, we observed that in the presence of chromosomal DSBs 
rAAV switches to a chromosome-initiated, ends-in recombination mode (Figure S3), 
which greatly augments the PGE process.  A detailed analysis of the intermediates of 
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the ends-in recombination reaction revealed that the DSBR model is preferred over 
SDSA and HJ dissolution in DSB-induced PGE using rAAV donors with central 
heterology.  These observations greatly expand our understanding PGE and its 
underlying HDR mechanism in human cells. 
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Results 
The HPRT targeting system 
The X-linked hypoxanthine phosphoribosyltransferase (HPRT) locus is widely used 
as a negative selection marker [70, 135].  Inactivation of HPRT by a single round of PGE 
confers 6-thioguanine resistance in male cells.  In our system, a rAAV targeting vector 
(Figure 1A) was assembled to disrupt exon 3 of HPRT (Figure 1B) with a neomycin-
resistance gene (NeoR) expression cassette.  Following G418 selection, PGE and 
random integration events could be distinguished based on their 6-thioguanine 
resistance or sensitivity.  In order to differentiate the viral DNA from its chromosomal 
counterpart, each homology arm of the virus was marked with 4 SNPs that generated 
unique restriction enzyme recognition sites.  In addition, a 22 bp hairpin structure, which 
is refractory to the MMR machinery [127, 136] that was generated by the inclusion of 3 
to 4 SNPs, was also introduced into each homology arm (Figure 1A).  The homology 
arms of the targeted and randomly integrated clones could be amplified from the 
integrated loci (Figure 1C) using diagnostic PCRs.  Primer pairs P1xP3 and P4xP6 
(PGE primers) specifically amplified the left and right homology arms of targeted clones, 
whereas P2xP3 and P4xP5 (random integration primers) amplified the randomly 
integrated clones with intact homology arms (Figure 1C).  The retention of the viral 
SNPs and hairpins was analyzed either by restriction enzyme sensitivity or DNA 
sequencing, or both. 
PGE is characterized by bidirectional conversion tracts with a linear distribution 
To elucidate the molecular mechanism of rAAV-mediated PGE, it was important to 
characterize which parts of the homology arms were integrated into the genome (the 
conversion tracts).  Since the retention of SNPs can be influenced by MMR, PGE was 
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initially performed in the MMR-deficient, male HCT116 and DLD-1 cell lines, which are 
deficient in MLH1/MSH3 and MSH6, respectively [137, 138].  In the later part of this 
paper we demonstrate that while the MMR status of a cell affects the frequency of PGE 
it importantly does not affect the SNP retention profile.  After rAAV infection, cells were 
selected with G418 and 6-thioguanine.  A total of 230 (for HCT116) and 92 (for DLD-1) 
correctly targeted clones were confirmed by PCR and analyzed for the retention 
frequency of viral SNPs, which was then plotted against the position of the SNPs on the 
homology arms (Figure 1E, 1F, Tables S1 and S6).  Strikingly, the viral SNPs were 
retained in a virtually linear gradient pattern: R2 equaled 0.981 and 0.996 for the left and 
right homology arms, respectively, in HCT116 cells (Figure 1E) and 0.945 and 0.991 for 
the left and right homology arms, respectively, in DLD-1 cells (Figure 1F).  The inner 
SNPs had the highest chance of retention, whereas the outer markers were mostly lost 
during PGE.  The linear distribution of conversion tracts suggested that the positions of 
HJ resolution were evenly distributed throughout the homology arms because when HJ 
resolution occurs, the viral homology arms distal to that position will not be retained.  
Importantly, the linear conversion tracts observed in human PGE contrast with the 
exponential conversion tracts reported for meiotic recombination in yeast and Drosophila 
and for mitotic recombination in yeast and mouse embryonic stem cells {[123, 131-134]; 
Figure S2}, which implied that the dynamics of HJ formation/resolution during PGE in 
human somatic cells may be different from similar processes in other organisms. 
To determine if the even distribution of HJ resolution was intrinsic to rAAV-
mediated PGE or was a general feature of PGE in human cells, a parallel transfection 
experiment was performed using a dsDNA donor that was identical to rAAV except that it 
was double-stranded and it did not contain the inverted terminal repeats (Figure 1D).  
Ultimately, 18 correctly targeted clones were recovered despite the extremely low 
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targeting efficiency of this approach.  SNP analysis revealed an indistinguishable linear 
retention curve (Figure 1G and Table S2).  Thus, the even distribution of HJ resolution 
is a general characteristic of PGE in human somatic cells, which led us to believe that 
rAAV, as a single-stranded virus, may target the human genome in a mechanism similar 
to dsDNA donors, i.e., via two-end, ends-out DSBR {[64, 122, 126]; Figure S3}. 
Homology arms remain mostly Intact during rAAV random integration 
While PGE is perforce mediated by homology-directed repair, random integration is 
believed to be mediated by the NHEJ pathways.  To test whether PGE and random 
integration produce different molecular products, 38 random clones were recovered and 
analyzed.  37 of these clones could be amplified by both sets of random integration 
primers (Figure 1C), indicating that the entire homology arms are almost always 
retained during random integration.  To rule out potential discontinuous homology arm 
incorporation, a SNP retention analysis was also performed upon the random integration 
clones.  Strikingly, all the SNPs were 100% retained on both arms of the random clones 
(Figure 1H and Table S3), which confirmed that the homology arms were incorporated 
intact during random integration.  This result is consistent with observations that AAV 
and rAAV viral:chromosomal DNA junctions reside almost exclusively within the viral 
inverted terminal repeats instead of the homology arms during random integration [139-
141].  The retention of intact viral homology arms during random integration, in contrast 
to the gradient SNP retention that occurred during PGE, unequivocally demonstrated 
that rAAV-mediated PGE and random integration are mediated by non-overlapping DSB 
repair pathways. 
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rAAV-mediated PGE occurs predominantly via DSBR instead of ssDI 
While only single-stranded genomes can be packaged into virions, rAAV becomes 
double-stranded during replication in the host cell [142].  To determine whether viral 
ssDNA or dsDNA was the major substrate for PGE, a sectoring assay [64, 123, 126] was 
performed in MMR-deficient HCT116 and DLD-1 cells (Figure 2A and 2B).  If double-
stranded viral substrates are used for PGE via DSBR (Figure 2A), both viral strands will 
be incorporated into a heteroduplex DNA intermediate with unequal length.  When this 
heteroduplex DNA intermediate is resolved by mitosis in situ, the two daughter cells will 
give rise to a heterogeneous colony containing genetically distinct cells that are 
reciprocally sectored for some of the SNPs on the homology arms (Figure 2A).  On the 
other hand, if PGE occurs via ssDI (Figure 2B), a single-stranded viral DNA will be 
annealed into the heteroduplex DNA.  Subsequently, the daughter cell lacking the 
selection marker will be killed during drug selection, whereas the other will grow into a 
homogenous colony with all the SNPs unsectored (Figure 2B).  Consequently, the 
relative contribution of DSBR and ssDI can be expressed as the ratio of the sectored to 
unsectored colonies produced by rAAV-mediated PGE. 
HCT116 and DLD-1 cells were infected and then allowed to grow into colonies in 
situ in G418- and 6-thioguanine-containing medium.  An amount of virus was used to 
make sure that on average only a single colony was formed in each plate.  SNP analysis 
revealed that 74% and 89% of targeted clones in HCT116 and DLD-1, respectively, were 
sectored on at least one side of the homology arms (Figure 3, Tables S4 and S6), 
consistent with the DSBR model.  Considering that this assay is unable to detect short 
heteroduplex DNA tracts formed between two neighboring SNPs, this result is likely an 
underestimation of the actual number of sectored colonies.  To rule out the possibility 
  32 
that the sectoring was generated from doublet colonies or two independent ssDI events, 
11 clones that were sectored on both arms were subjected to single-cell subcloning.  
Sequencing analyses demonstrated that 89.6% of the subclones segregated the SNPs 
with a perfect trans configuration (Table S5).  Since colonies produced by two 
independent PGE events will have an equal chance to be trans or cis, the empirically-
observed biased trans:cis ratio indicated that most colonies were generated by a single 
DSBR event.  Thus, in contrast to popular belief, rAAV-mediated PGE is predominantly 
mediated by DSBR in human cells.  Nevertheless, since a fraction (26% for HCT116 and 
11% for DLD-1) of the targeted clones remained unsectored, we cannot rule out the 
possible involvement of ssDI as a minor pathway. 
The efficiency of rAAV-mediated PGE correlates with the DSBR activity  
To confirm that rAAV-mediated PGE efficiency correlated with DSBR, and not ssDI, 
activity, we transfected HCT116 cells with Rad51K133A, a dominant negative form of 
Rad51 reported to reduce DSBR and concomitantly elevate SSA [134].  Using episomal 
reporters for either the total non-crossover products from HDR (Figure 4A) or SSA 
(Figure 4B), we confirmed that expression of the dominant negative indeed reduced 
DSBR and increased SSA in HCT116 cells (Figure 4C).  Importantly, the rAAV targeting 
efficiency at the HPRT locus was reduced by 6.2-fold upon Rad51K133A transfection, 
which correlated well with the reduced DSBR activity and not the increased SSA activity 
in these cells (Figure 4C).  Thus, consistent with the sectoring assay, this result further 
confirmed that rAAV-mediated PGE is mediated predominantly by DSBR instead of ssDI 
in human cells. 
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The process of rAAV-mediated PGE is inverted in the presence of DSBs 
Spontaneous endogenous DSBs occur around 10 times per mammalian cell per 
day [15].  The likelihood that one of these DSBs must be introduced near a target locus 
in order for rAAV-mediated PGE to occur is statistically improbable.  rAAV-mediated 
PGE must, therefore, employ a mechanism that is independent of the formation of 
chromosomal DSBs (Figure 2A).  Nevertheless, rAAV-mediated PGE can be stimulated 
dramatically by the presence of chromosomal DSBs near the target locus [51-53].  The 
mechanistic basis for this increase is, however, not understood.  To investigate this 
issue, rAAV was used to “knock-in” an I-SceI enzyme recognition sequence onto the X 
chromosome at a site that corresponded to a position (nt 266), just to the right of the 
SacI (nt 261) site, on the right homology arm of the HPRT rAAV targeting vector (Figure 
5A, 5B and Figure S4).  After transfection with an I-SceI expression plasmid, 
chromosomal DSBs were quantified by ligation-mediated PCR {[143]; Figure 5D}.  DSBs 
were detectable 16 hr after transfection, and peaked ~24 hr after transfection (Figure 
5E).  Accordingly, rAAV infections were performed either 12 or 20 hr after I-SceI 
transfection in an attempt to coordinate the viral infection with the chromosomal DSB 
induction.  The absolute PGE efficiency increased by 477- and 582-fold, respectively, in 
the presence of I-SceI (Figure 5F), which was consistent with previous reports [51-53].  
The random integration frequency was virtually unperturbed by the expression of I-SceI 
(Figure 5F).  The retention of viral SNPs was then analyzed in 64 targeted clones.  
Strikingly, the SspI and SacI sites on the right homology arm were both retained at 100% 
frequency (Figure 5G and Table S7), which was in stark contrast to the linear gradient 
of SNP loss in spontaneous PGE (compare Figure 5G with Figure 1E and 1F).  The 
SNPs to the right of the I-SceI site (the RHP, XbaI and SbfI) were lost in a sharper, but 
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nonetheless linear, gradient (Figure 5G).  To confirm this finding, we constructed 
another cell line in which rAAV was used to knock-in an I-SceI enzyme recognition 
sequence into the X chromosome at a site that corresponded to a position (nt -569), just 
to the left of the NcoI (nt -547) site, on the left homology arm of the HPRT rAAV targeting 
vector (Figure 5A, 5C and Figure S4).  The rAAV-mediated PGE frequency was also 
elevated by concomitant I-SceI expression (Figure 5F).  The retention of viral SNPs was 
then analyzed in 48 targeted clones.  In a strikingly mirrored fashion, the AseI and NcoI 
sites on the left homology arm were both retained at 100% frequency, while the SNPs to 
the left of this region (the LHP, EcoRI, NdeI) were lost in a linear gradient (Figure 5H 
and Table S8). 
The plateaued conversion tracts observed in these 2 experiments are predicted 
from an “ends-in” DSBR model in which recombination is initiated not by the vector DNA 
but by the broken chromosome (Figure 6A).  In contrast to spontaneous rAAV PGE 
where the viral DNA “attacks” the unbroken chromosome in an ends-out configuration 
(Figure 2A), in DSB-induced PGE the broken chromosomal ends are instead processed 
and invade the virus in an ends-in configuration (Figure 6A and Figure S3).  Without 
drug selection, the random distribution of HJ resolution would produce linear conversion 
tracts peaking at the I-SceI site (Figure 6A-1; cartooned for the rightward I-SceI site).  
However, because G418 selection was imposed, any HJs that were resolved between 
the I-SceI site and the selection cassette would have been lost.  Consequently, the 
initiation of recombination with the chromosomal I-SceI-restricted ends and the 
requirement for the retention of the viral selection cassette precisely explain the 
conversion tracts that we obtained (compare Figure 5G with Figure 6A-2).  In summary, 
the introduction of a chromosomal DSB inverts the process of PGE such that the viral 
DNA becomes the “attackee” instead of the attacker. 
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These data also established an important corollary.  Three pathways can act 
independently to resolve an HDR intermediate: the DSBR model, HJ dissolution and 
SDSA {[144, 145]; Figure 6}.  DSBR features the formation and resolution of double HJs 
(Figure 6A) whereas inward branch migration of the HJs can cause HJ dissolution 
(Figure 6B).  Alternatively, in SDSA the synapse collapses before the formation of the 
second HJ (Figure 6C).  SDSA is believed to be the major pathway of mitotic 
recombination in yeast and plants [146, 147].  It is also the preferred pathway of 
repairing an I-SceI-induced DSB in mouse and human cells [33].  Importantly, both the 
SDSA and HJ dissolution models predict unidirectional conversion tracts with the 
retention of one half of the I-SceI site and the loss of all of the SNPs rightward of the 
right I-SceI site (Figure 6-3), or leftward of the left I-SceI site (not shown), a minor 
pattern that was observed in only 17% of the clones (Table S7).  Collectively, these 
results suggest that although SDSA may be the major pathway for recombination in 
mitotic cells, the DSBR model is the predominant form of HDR that leads to PGE in 
human somatic cells using rAAV or dsDNA donors with central heterology. 
The strong inhibitory role of MLH1 on PGE via its anti-recombination activity 
Since the SNPs engineered into the rAAV targeting vector generated mismatches 
in the heteroduplex DNA intermediate, we wished to assess if they were sensitive to 
MMR.  Thus, another rAAV targeting vector was constructed with only 2 SNPs and 
tested in the parental HCT116 (MMR-deficient) cell line (Figure 7A).  The targeting 
efficiency was 7.5-fold higher compared to the original vector, which contained 15 SNPs 
(Figure 7B).  These data indicated that the presence of mismatches deleteriously 
affected PGE even in a MMR-reduced background, a result that can be attributed to the 
residual MMR activity present in this cell line [148].  To further address the role of the 
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MMR system, PGE was performed in an MMR-proficient variant (MLH1+), in which the 
mutated MLH1 gene in HCT116 cells was corrected by rAAV-mediated knock-in (Figure 
7B, inset).  Targeting efficiency decreased by more than 50-fold in MLH1+ cells for each 
of the vectors respectively compared with the isogenic MLH1-defective parental line 
(Figure 7B).  Collectively, these data demonstrated that the MMR gene MLH1 exerts a 
strong inhibitory effect on PGE [123, 149]. 
Mismatch repair has two well-documented activities.  One is as a “spell-checker” to 
correct post-replication mismatches in DNA and the other is as an “anti-recombinase”, 
by impeding the formation of homeologous heteroduplex DNA [149, 150].  To assess 
which of these two activities was responsible for reducing PGE, 20 targeted clones were 
recovered — despite the extremely low targeting efficiency in MLH1+ cells — and 
analyzed for SNP retention (Figure 7C and Table S9).  Importantly, the SNP retention 
curve for MLH1+ cells was indistinguishable from the parental (MLH1-) linear retention 
curve (compare Figure 1E and F with Figure 7C).  Moreover, the hairpins, which are 
refractory to the spell-checking activity of MMR [127, 148], were retained at the same 
frequency as is predicted by the linear regression of other SNPs, which are substrates 
for spell-checking.  Finally, the percentage of discontinuous gene conversion tracts (a 
hallmark of spell-checking) did not change significantly in the MMR-proficient, compared 
to the MMR-deficient, background (compare Table S9 with Table S1, respectively).  
These results demonstrated that the presence of MLH1 exercised no detectable spell-
checker activity upon the mismatches in the heteroduplex DNA intermediate and implied 
that the large, negative impact of MLH1 on PGE was instead due to anti-recombination 
activity of MMR [123, 149, 150].  Finally, to test whether the MMR system affects 
random integration, 22 G418-resistant 6-thioguanine-sensitive clones were recovered 
from the MLH1+ background and analyzed for SNP retention.  All but one of them could 
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be amplified using the random integration primers, and once again, 100% of the viral 
SNPs were retained (Figure 7D and Table S10), which is consistent with the observation 
that MMR does not affect NHEJ [150]. 
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Discussion 
rAAV uses the DSBR model of HDR for PGE 
Although rAAV is widely used in laboratory and clinical studies, the mechanism of 
rAAV-mediated PGE has remained obscure.  Since rAAV is packaged exclusively as a 
single-stranded virus, several reports have suggested that rAAV-mediated PGE is 
mediated by ssDI [42, 43].  Moreover, the ssDI model is supported by indirect evidence 
that minute virus of mouse, a related parvovirus, shows a strand-specific bias in PGE 
[151].  Our data, however, using three lines of evidence demonstrate that rAAV-
mediated PGE is mediated by the DSBR model of HDR using double-stranded viral 
substrates: (1) rAAV-mediated PGE produces conversion tracts indistinguishable from 
those of dsDNA-mediated PGE, which is dictated by two-end, ends-out DSBR [64, 126].  
(2) rAAV-mediated PGE is associated with the formation of sectored colonies in a trans 
configuration, which is characteristic of the DSBR model.  (3) rAAV-mediated PGE 
frequency correlated with DSBR, and not SSA, activity through the use of Rad51K133A 
transfections.  These results demonstrate that rAAV has to become double-stranded — 
either by host DNA polymerases or by annealing of the plus and minus viral strands — 
before targeted integration can occur. 
What is less clear, given that rAAV uses the same mechanism as dsDNA donors, 
is why rAAV targets human cells so much more robustly.  We suggest that there are 
several viral elements of rAAV that may positively influence PGE.  For example, the 
capsid proteins may facilitate virus transduction and nuclear trafficking via interaction 
with cellular receptors [152] to generate higher nuclear concentrations of the viral DNA 
versus transfected DNA.  In addition, the hairpin-structured inverted terminal repeats 
may serve as physical barriers to protect the ends of the viral genome from nuclease 
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degradation during nuclear trafficking.  An alternative possibility that we favor is that the 
inverted terminal repeats may facilitate the formation of active recombination substrates.  
Thus, besides the recombinogenic linear viral dsDNA, infected cells also contain a 
mixture of viral ssDNA along with circular and concatemerized dsDNA [153].  Our ends-
out recombination model requires that both ends of the viral genome are accessible to 
exonuclease resection, which means that the linear, monomeric double-stranded viral 
genomes are the only active substrates that can be used for PGE.  Since the inverted 
terminal repeats suppress the intra- and intermolecular recombination that generates 
viral circular and concatemerized dsDNA [154], they may facilitate PGE by favoring the 
existence of the active recombination substrates.  On the contrary, dsDNA-mediated 
PGE vectors may be efficiently inactivated by circularization or concatemerization before 
PGE can occur.  Needless, to say, none of these hypotheses are mutually exclusive and 
they may act synergistically to enhance rAAV-mediated PGE. 
rAAV-mediated PGE as a model to study DSBR in human somatic cells 
The locations of crossovers are determined by the initial positions of HJ formation 
and branch migration activity.  Comprehensive gene conversion analyses have been 
performed in yeast, flies and mouse embryonic stem cells, which revealed short 
conversion tracts with exponential distribution during meiotic and mitotic HDR {[123, 
131-133]; Figure S2}.  These studies indicated that the crossovers were more likely to 
be resolved or dissolved near the initiation site of strand invasion, probably as a result of 
branch migration.  Although similar studies have been undertaken in mammalian 
systems [33, 125-128, 155] the generality of the conclusions were restricted by the 
limited scale of the data.  Taking advantage of the high targeting efficiency of rAAV, we 
performed a conversion tracts analysis for spontaneous (Figure 1E and 1F) and DSB-
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induced (Figure 5G and 5H) PGE in human cells with unprecedented resolution.  In 
contrast to previous studies, we obtained long conversion tracts with linear distribution, 
indicating that crossovers are evenly, and not exponentially, distributed along the 
homology arms in the DSBR model.  We further confirmed the generality of the 
conversion tracts using dsDNA-mediated PGE, although on a smaller scale (Figure 1G).  
Assuming that each segment of the homology arms has the same tendency to initiate 
strand exchange [156], we propose that the linear conversion tracts in human cells are 
shaped primarily by the even distribution of HJ formation and is minimally impacted by 
branch migration in the DSBR model.  It should be noted that alternative scenarios are 
possible.  For example, rather than formation of a second HJ (Figure 2A), the distal 
ends could be resolved by cleavage with structure-specific endonucleases such as 
XPF/ERCC1 [157, 158].  Our linear conversion tracts favor the former scenario, but we 
cannot rule out the latter possibility. 
 Branch migration reshapes the distribution of crossovers and determines the 
amount of genetic information exchanged during HDR.  Interestingly, bacterial RecA and 
its mammalian Rad51 homologs facilitate branch migration in different directions: RecA 
moves the HJs away from DSBs to encourage the exchange of genetic material in 
bacteria, whereas in lower eukaryotes, Rad51 shifts the HJs towards DSBs to minimize 
gene conversion tracts [159].  Our results are consistent with the in vitro observation that 
the branch migration activity of human Rad51 is substantially lower than its yeast 
counterpart [159], which suggests that human cells may have adopted an energy-saving 
strategy to repair somatic DSBs by HDR without suppressing the amount of genetic 
material in the exchange. 
An additional insight from our studies is the demonstration that meganucleases 
stimulate PGE by promoting chromosome-initiated, ends-in DSBR.  Creating a DSB in a 
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target locus increases the frequency of PGE by 2 to 3 orders of magnitude {[51-53, 160]; 
Figure 5F}, which makes artificial meganucleases promising tools for genetic 
engineering.  The mechanism for the enhanced PGE frequency was, however, unknown.  
Importantly, our chromosome-initiated ends-in DSBR model immediately provides an 
explanation for this profound enhancement.  As discussed earlier, the viral DNA inside 
an infected cell can exist as linear, circular or concatemeric species and only the former 
of these is proficient for ends-out recombination.  Since the majority of the viral genomes 
are converted into circular or concatemeric forms by cellular DSB repair pathways 
shortly after infection [142, 153] the efficiency for spontaneous PGE is low.  In contrast, 
in DSB-induced PGE, the broken chromosome ends can invade all of these exogenous 
species to initiate HDR.  Also, this ends-in DSBR involves the resolution of only two — 
instead of the four — HJs required for the ends-out DSBR. These differences may 
together contribute to the orders of magnitude increase in targeting efficiency. 
The demonstration of two modes for PGE explains an additional conundrum in the 
field.  Thus, by themselves, ODNs are poor  donors for PGE in mammalian cells [161].  
Paradoxically, with the development of artificial meganucleases, ZFNs [85], TALENs [86] 
and CRISPR/Cas9 [162], there has been a spate of recent papers demonstrating that 
single-stranded oligonucleotides can be efficiently used to facilitate HDR in the presence 
of a DSB {e.g., [163, 164]}.  This “paradox” however, is precisely what our data would 
predict: by itself, ODNs would need to engage an endogenous genomic lesion to initiate 
PGE via the minor HDR pathways (e.g., ssDI).  In contrast, following a meganuclease-
induced DSB, the resulting chromosomal ends should efficiently and productively be 
able to interact with accompanying ODN donors via SDSA. 
Finally, our data demonstrate that the DSBR model is the preferred HDR pathway 
leading to PGE using rAAV or dsDNA donors with central heterology in human cells.  
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The DSBR model has become the paradigm of HDR in yeast [130], which is 
characterized by the formation of double HJs and resolution by resolvases (Figure 6A).  
However, this model has been challenged in mammalian cells by the fact that mitotic 
recombination is infrequently associated with crossovers.  SDSA emerged as an 
alternative model [165], in which the invading strand anneals back with its original 
partner after de novo DNA synthesis without the formation of HJs (Figure 6C).  In plants 
and mammals, a large body of evidence suggests that SDSA is the preferred pathway of 
mitotic recombination [33, 146, 147].  There is less convincing data that SDSA is utilized 
for PGE, although it should be noted that the ERCC1/XPF nuclease complex, which has 
documented roles in SSA and in SDSA [158], can impact the process of mammalian 
PGE as well [166].  Our conversion tracts analysis in the presence of a chromosomal 
DSB, however, indicated that the bulk of the PGE products are generated by the DSBR 
model, at least when the conversion of a large drug selection marker is required (Figure 
6A).  This result strongly argues that — in human somatic cells — PGE using dsDNA 
donors, including rAAV, is most accurately described by the DSBR model. 
In toto, it should also be emphasized that there are a multitude of differences, 
some subtle and some not so that distinguish human PGE from that described in other 
systems: e.g., 1) the even distribution of crossovers in the homology arms, 2) the 
preferred use of DSBR versus SDSA or HJ dissolution, and 3) the preferential use of 
broken chromosomal ends over the ends of exogenous DNA.  Understanding the 
mechanistic underpinnings of these differences will be critical to improve the efficacy of 
PGE for therapeutic purposes. 
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Figures and Legends  
 
Figure 1.  PGE is characterized by linear conversion tracts  
(A) The rAAV PGE donor.  The NeoR cassette (white rectangle) is flanked by the 
homology arms (green and blue rectangles).  NdeI, EcoRI, NcoI, AseI, SspI, SacI, XbaI 
and SbfI represent vector-borne restriction sites created by SNPs.  LHP/RHP represent 
vector-borne palindromes (lollipops) created by introducing SNPs.  The flanking hairpins 
represent inverted terminal repeats.  (B and C) The HPRT locus before and after PGE.  
The NeoR cassette replaces exon 3 (grey) of HPRT upon PGE.  The theoretical positions 
of the viral markers are indicated in bold vertical lines and (?) symbols.  The arrows 
represent PCR primers.  P1xP3 and P4xP6 amplify the left and right homology arms of 
the gene targeted clones, respectively, and P2xP3 and P4xP5 amplify the homology 
arms of the randomly integrated clones, respectively.  The LHP destroys a chromosomal 
BbvCI restriction site upon integration.  (D) The dsDNA PGE donor.  All symbols are 
defined above.  (E, F, G and H) SNP retention signatures of rAAV-mediated PGE for 
HCT116 and DLD-1 cell lines, dsDNA-mediated PGE and random integration, 
respectively.  The distance to the central heterology (cartooned as a vertical black line) 
is calculated from the inner ends of the homology arms.  Markers on the left homology 
arms are indicated with negative distances.  Green and purple lines represent the linear 
regression between the retention frequency and the distance of the viral markers for the 
left and right homology arms, respectively. 
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Figure 1 
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Figure 2.  Models for rAAV-mediated PGE 
(A) The DSBR model.  Black, red and blue lines correspond to genomic DNA, viral 
and genomic homology arms, respectively; the bold green line corresponds to the 
selection cassette.  The vertical arrows imply that the viral DNA becomes double-
stranded and the inverted terminal repeats are processed before integrating into the 
genome.  Open arrows represent the sites of HJ cleavage and ligation.  A sectored 
colony is formed during mitosis.  (B) The ssDI model.  All symbols are as in (A).  The 
virus that anneals to the genomic DNA is single-stranded.   In the ensuing mitosis, an 
unsectored colony is formed under drug selection. 
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Figure 2 
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Figure 3.  rAAV-mediated PGE forms sectored colonies  
Solid boxes on the top (not to scale) represents diagnostic markers on the virus 
(blue) and genomic DNA (yellow).  The numbers indicate the actual positions of the 
markers. The NeoR cassette and exon 3 of HPRT are indicated in white and grey, 
respectively.  Each line on the bottom corresponds to an independent PGE event.  The 
blue, yellow and green segments are color-coded to represent viral, genomic and 
sectored tracts, respectively.  The top and bottom panels show results obtained from 
HCT116 and DLD-1 cells, respectively. 
 
  
  48 
 
Figure 3 
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Figure 4.  The efficiency of rAAV PGE correlates with the DSBR activity 
(A) The DSBR assay.  SceGFP is a full-length GFP gene disrupted by an I-SceI 
site.  DSBR between SceGFP and the internal GFP (iGFP) fragment on the same 
plasmid upon I-SceI digestion restores GFP activity.  (B) The SSA assay.  5’GFP and 
3’SceGFP are GFP fragments bearing 266 bp of homology.  SSA repair of the I-SceI-
induced DSB generates a functional GFP gene.  (C) The efficiency of DSBR, SSA and 
rAAV-mediated PGE.  The indicated cell lines were analyzed using the DSBR and SSA 
assays as well as for rAAV-mediated PGE.  The mean ± SEM of three independent 
experiments is shown. 
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Figure 5.  DSB-induced PGE generates plateaued conversion tracts 
(A) The rAAV PGE donor.  See the legend to Figure 1A for details.  (B) The HPRT 
locus.  An I-SceI restriction site (orange) was knocked-in to the chromosome at the 
indicated corresponding vector position.  The lightning bolt denotes that DSBs can be 
induced upon I-SceI expression.  (C) The HPRT locus; left side analysis.  All symbols as 
in (B).  (D) Scheme for the LM PCR.  A linker with a 5’ I-SceI overhang was ligated to the 
3’ end of the genomic I-SceI-generated break.  The presence of a ligation product was 
quantitated with the primers indicated by arrows.  (E) I-SceI-induced chromosomal DSBs 
can be detected within 24 hr of I-SceI expression.  A gel electrophoresis analysis of the 
PCR products generated using genomic DNA isolated at the indicated times following I-
SceI expression.  β-Actin was used as a loading control.  (F) The efficiency of I-SceI-
induced rAAV PGE.  Cells were infected with rAAV without (Ctrl) or 12 or 20 hr (for the 
right side) or 24 hr (for the left side) after I-SceI expression.  The PGE and random 
integration frequencies were normalized to the no I-SceI control.  (G) The conversion 
tracts of I-SceI-induced rAAV-mediated PGE; right side.  The dotted orange line 
indicates the position of the I-SceI site.  All other symbols are defined in Figure1A.  (H) 
The conversion tracts of I-SceI-induced rAAV-mediated PGE; left side.  All symbols are 
as in (G). 
 
  
  52 
 
Figure 5 
 
 
    
  53 
 
Figure 6.  Models for DSB-induced rAAV PGE  
(A) rAAV-mediated PGE in the presence of DSBs.  Dotted lines and arrowheads 
correspond to de novo DNA synthesis, which is color-coded to match the templates.  
Orange slashes represent half I-SceI sites and the lightning bolt represents I-SceI-
induced cleavage.  All other symbols are as in Figure 2. The chromosomal ends are 
processed and invade the viral DNA in an ends-in configuration.  Two predicted SNP 
retention patterns (minus and plus drug selection, respectively) are cartooned as (1) and 
(2), respectively.  (B) HJ dissolution.  Branch migration forces the HJs towards the drug 
selection cassette and the HJ is cancelled.  The predicted SNP retention pattern is 
cartooned in (3).  (C) SDSA.  If the synapsed structure shown in (A) collapses, 
recombination can still occur by SDSA.  This mechanism, like HJ dissolution (B), 
predicts the SNP retention pattern shown in (3). 
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Figure 7.  rAAV PGE is suppressed in a mismatch repair-proficient background   
(A) The rAAV PGE donors.  All symbols as in Figure1A.  2SNPs and 15SNPs 
indicate the total number of mismatches in the vectors.  (B) Effects of mismatches and 
the host mismatch repair status on rAAV mediated PGE.  The efficiency of rAAV 
mediated PGE is expressed as the ratio of PGE events divided by the sum of the PGE 
plus randomly integrants.  All results are normalized to the parental (MLH1-) cell line.  
The mean ± SEM of three independent experiments is shown.  The MLH1 expression in 
the parental and MLH1+ cell lines is shown in the inserted Western blot panel.  b-actin 
was used as a loading control.  (C and D) The SNP retention signature of rAAV 
mediated PGE and random integration, respectively, in the mismatch repair (MLH1+) -
proficient background.  All symbols are as in Figure 1E. 
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Figure S1.  Overview of rAAV production and PGE  
A cartoon strategy for rAAV virus production and PGE is shown.  At the top left are 
cartooned three plasmids that contain i) the AAV viral genes: Rep (orange rectangle) for 
replication and Cap (purple rectangle) for capsid, ii) the rAAV vector containing a 
backbone (purple lines), the ITRs (bubbles), HAs (red lines) and the selection cassette 
(green box) and iii) the plasmid encoding adenoviral (Ad) helper functions (gray 
rectangle).   These three plasmids are triple transfected into AAV293 cells, where the 
viral and Ad helper proteins are expressed and facilitate the replication of the viral DNA.  
Virions (hexagons), containing single-stranded rAAV, are subsequently collected from 
the supernatant of these cells and used to infect a target cell.  In the target cell, the rAAV 
once again assumes a double-stranded form and facilitates PGE at your favorite gene 
(YFG). 
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Figure S2.  Schematic illustrations of the difference in conversion tracts of lower 
organisms and human somatic cells   
In all organisms, the process of PGE appears to be initiated with the same steps: 
strand resection (PacManTM) and HJ formation.  The blue lines represent chromosomal 
DNA, the red lines viral DNA and the green lines the selection cassette.  In yeast, flies 
and murine ES cells, the process of branch migration (orange arrows) pushes the HJs 
towards each other (left), whereas in human cells this process is apparently negligible.  
HJ resolution (small white arrows) of these structures generates either an exponential 
SNP retention curve (in the presence of inward branch migration, left) or a linear SNP 
retention curve (in the absence of branch migration, right).  The amount of genetic 
information that is exchanged is correspondingly restricted (left) or enlarged (right). 
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Figure S3.  Definitions of ends-out and ends-in recombination  
A cartoon of a chromosome (blue oval with yellow circular centromere) and a PGE 
vector (red lines) containing a drug selection cassette (green rectangle) is shown.  In the 
ends-out recombination, the 3’ ends of the targeting vector invade (black lines with 
arrowheads) — in directions opposite to each other — the chromosome in separate 
HDR reactions.  In the spontaneous ends-in recombination, the 3’ ends of the targeting 
vector invade the chromosome in directions facing each other.  In the chromosomal 
DSB-induced ends-in recombination, the broken chromosomal ends (jagged blue ovals) 
invade/anneal to the targeting vector in directions facing each other. 
  
  62 
 
Figure S3 
 
 
  
  63 
 
Figure S4.  Knock-in of I-SceI sites into the HPRT locus  
A cartoon of a rAAV I-SceI knock-in PGE donor is shown on the top line.  The I-
SceI recognition site is shown a double-hatched line.  A cartoon of the relevant portion of 
the HPRT locus (horizontal line with a rectangular exon 3) is shown on the line below.  
Following correct GTing, both the I-SceI recognition site and the NeoR drug resistance 
gene are integrated at the HPRT locus.  Following Cre recombination, the NeoR gene is 
removed and a solo LoxP scar (shaded triangle) remains. 
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Table S1.  Conversion tracts of rAAV-mediated PGE in parental HCT116 cells 
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Table S2.  Integration tracts of rAAV random integration in parental HCT116 cells 
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Table S3.  Conversion tracts of dsDNA-mediated PGE in parental HCT116 cells 
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Table S4.  The sectoring assay in parental HCT116 cell 
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Table S5.  Subcloning of the selected colonies from Table S4 
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Table S6.  The sectoring assay in parental DLD-1 cells 
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Table S7.  Conversion tracts of I-SceI-induced rAAV PGE on the right arm 
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Table S8.  Conversion tracts of I-SceI-induced rAAV PGE on the left arm 
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Table S9.  Conversion tracts of rAAV-mediated PGE colonies in MLH1+ cells 
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Table S10.  Integration tracts of rAAV random integration in MLH1+ cells 
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Materials and Methods 
Cell culture 
The HCT116 and DLD-1 cell lines were cultured in McCoy’s 5A medium 
supplemented with FBS, L-glutamine, penicillin and streptomycin with 5% CO2 at 37 ℃. 
Cell lines and plasmids 
The HCT116 cell line was obtained from ATCC.  The MLH1+ cell line was provided 
by Horizon Discovery, Ltd.  The DLD-1 cell line was obtained from Dr. D. Largaespada.  
The DR-GFP and SA-GFP reporter plasmids were obtained from Dr. M. Jasin and the 
Rad51K133A expression vector was obtained from Dr. J. Stark [134]. 
Viruses 
Briefly, the left and right homology arms were amplified by PCR from HCT116 
genomic DNA.  Viral SNPs were introduced using a QuickChangeTM site-directed 
mutagenesis kit.  The arms were then joined with a drug selection cassette using fusion 
PCR and the resulting product was ligated to a pAAV backbone.  All virus packaging and 
infections were performed as described [129]. 
Conversion tracts analysis 
Genomic DNA was Isolated and the homology arms of the GT and RI clones were 
amplified by diagnostic PCRs (Figure 1C).  The retention of the vector-borne markers 
was analyzed first by restriction enzyme digestion and then confirmed by sequencing. 
Repair assays 
Briefly, cells were subcultured in 6-well tissue culture plates.  The next day, the 
cells were transfected with 0.5 µg mCherry, 1.0 µg of an I-SceI expression plasmid and 
  76 
1.0 µg DR-GFP or SA-GFP assay substrates.  GFP and mCherry expression was then 
analyzed 48 hr post transfection using flow cytometry.  The repair efficiency was 
calculated as the percentage of GFP and mCherry doubly positive cells divided by the 
mCherry-positive cells.  For the Rad51DN experiment, an additional 1.0 µg of the 
Rad51K133A expression plasmid was transfected as well. 
The targeting efficiency assay at the HPRT locus 
Briefly, cells were subcultured in 6-well tissue culture plates on day 1.  On day 2, 
100 µl of the appropriate viral stock was added to the wells.  On day 4, the cells were 
counted and aliquoted into 10 cm tissue culture dishes for drug selection.  The plates 
were supplemented with 1 mg/ml G418 or 0.5 mg/ml G418 plus 5 µg/ml 6-thioguanine 
for 12 days.  The PGE and random integration efficiencies were calculated as the 
number of G418-resistant 6-thioguanine-resistant and G418-resistant 6-thioguanine-
sensitive colonies per 106 cells, respectively.  Results were averaged from 7 plates.  For 
the Rad51DN experiment, cells were transfected with 2.5 µg Rad51K133A expression 
plasmid 48 hr before infection.  For the I-SceI experiments, cells were transfected with 
2.5 µg of an I-SceI expression plasmid 12 or 20 hr before infection. 
Ligation-mediated PCR 
Genomic DNA was isolated at the designated times after I-SceI induction.  DNA (1 
µg) was ligated with 100 pmol of adaptors at 16℃ overnight.  PCR was performed at the 
linear stage using a 25 ng ligation product with the primers illustrated in Figure 5D.  β-
actin primers were used as loading control. 
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CHAPTER III: THE MECHANISMS OF PRECISE GENOME 
ENGINEERING USING ODN DONORS 
  
  78 
Summary 
The use of programmable meganucleases is quickly transforming genome editing 
and functional genomics.  CRISPR/Cas9 was developed such that targeted genomic 
lesions could be introduced in vivo with unprecedented ease.  In the presence of 
homology donors, these lesions facilitate high-efficiency precise genome editing (PGE) 
via the homology-directed repair (HDR) pathways.  However, the identity, property and 
hierarchy of the HDR pathways leading to the formation of PGE products remain elusive. 
Here we established an EGFP > BFP conversion system to systematically 
characterize oligonucleotide (ODN)-mediated PGE using Cas9 and its nickase variants 
in human cells.  We demonstrate that, unlike dsDNA donors with central heterologies, 
ODNs generated short conversion tracts with Gaussian distributions.  Interestingly, 
single nick-induced PGE using ODN donors produced either unidirectional or 
bidirectional conversion tracts depending on the relative strandedness of the ODNs and 
the nick.  Moreover, the ODNs were physically incorporated into the genome only in the 
bidirectional, but not in the unidirectional, conversion pathway.  In the presence of 
compound genomic lesions, the unidirectional conversion pathway was preferentially 
utilized even though the knock-in mutation could theoretically be converted by both 
pathways.  Collectively, our results demonstrate that ODN-mediated PGE utilizes the 
synthesis-dependent strand annealing and single-stranded DNA incorporation pathways.  
These pathways generate short conversion tracts with Gaussian distributions.  Although 
synthesis-dependent strand annealing is preferentially utilized, our work unequivocally 
establishes the existence of a robust single-stranded DNA incorporation pathway in 
human cells.  This work extends the paradigms of HDR-mediated gene conversion and 
establishes practical guidelines for PGE in human cells.  
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Introduction 
Genome editing is the intentional alteration of the genetic information in living cells 
or organisms.  Since Clustered Regularly Interspaced Short Palindromic 
Repeat/CRISPR-associated 9 (CRISPR/Cas9) was repurposed for genome editing [56-
60], the speed of CRISPR methodology is quickly bridging the genotype and phenotype 
worlds and facilitating high-throughput reverse genetic studies [94-99].  In the CRISPR 
age, targeted genomic lesions can be introduced with unprecedented ease, which 
facilitate either high-efficiency gene disruption by non-homologous end joining (NHEJ) or, 
in the presence of donor DNA, precise genome editing (PGE) by homology-directed 
repair (HDR) [12].  Research models of the desired genotype can be expeditiously 
generated within one cell cycle of most genetically-tractable organisms [100-103], and 
within one round of subcloning of cultured cells [167, 168].  Although HDR is the more 
desirable pathway for genome editing and gene therapy, its activity is much lower than 
NHEJ and highly dependent on the cell cycle status in human cells [8, 16, 50].  Thus, 
marker-free PGE still requires the laborious screening of hundreds of subclones, 
especially in hard-to-transfect cells or those with low HDR activity or limited tolerance of 
genomic lesions.  Moreover, bi-allelic and multiplexed PGE is still challenging in human 
cells. 
Complicating our understanding, HDR is composed of at least six different 
pathways in eukaryotic cells [7, 21].  Four of these pathways can lead to PGE without 
significantly sacrificing genomic stability - the double-strand break repair (DSBR) model 
[22, 23], Holliday junction dissolution [26-28], synthesis-dependent strand annealing 
(SDSA) [31-33] and single-strand DNA incorporation (ssDI, also sometimes referred to 
as single-strand assimilation) [38-40] pathways (Figure S1).  PGE is defined by the 
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fraction of HDR events leading to the conversion of desired knock-in mutations using 
exogenous homology donors.  Importantly, the identity, property and hierarchy of usage 
of the HDR pathways leading to the formation of PGE products remains a knowledge 
barrier that hinders the improvement of PGE. 
In the previous chapter, we demonstrated that in human somatic cells the 
introduction of large knock-in mutations with dsDNA donors (including transfected 
plasmids or viruses with dsDNA intermediates) must engage the DSBR pathway for 
PGE [169].  Interestingly however, many laboratories have reported that single-stranded 
oligonucleotides (ODNs) can be used to also obtain robust PGE [72-76].  This is 
surprising since ODN donors are likely physically unable to form Holliday junctions and 
therefore cannot engage DSBR.  Instead they must perforce utilize some form of the 
SDSA or ssDI pathways during PGE [39, 170].  In the absence of a targeted 
meganuclease like Cas9, the ODN donors likely must use spontaneously occurring 
genomic lesions in order to perform PGE.  Indeed, it was proposed that ODNs could be 
incorporated into the gaps generated by nucleotide excision repair [72, 73] or lagging 
strand synthesis during DNA replication [74-76], although the specific mechanisms are 
still disputed [77, 78].  Interestingly, both of these models involve the physical 
incorporation of the ODNs into the genome via an ssDI-like mechanism; a prediction that 
was later supported by experiments carried out by Radecke et al [38].  Confusingly, 
however, the same group of authors also demonstrated that ODNs could not be 
detected being physically incorporated into the genome during double-strand break 
(DSB)-induced PGE, suggesting the existence of an alternative mechanism(s) [79].  
Finally, in the presence of meganuclease-induced targeted single-strand nicks, it was 
proposed by Davis and Maizels that certain forms of the SDSA and the ssDI pathways 
could be utilized depending on the strandedness of the donor ODNs [40, 80].  However, 
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the exact mechanisms, conversion tracts and hierarchy of these pathways have 
remained elusive. 
Here, we have systematically dissected the molecular mechanisms of ODN-
mediated PGE induced by Cas9, Cas9 D10A nickase (nCas9) and paired-nickases 
using two lines of evidence: the directionality of the conversion tracts and the physical 
incorporation of the ODN donors.  We demonstrate that ODN-mediated PGE utilizes the 
SDSA and ssDI pathways.  In contrast to DSBR, these pathways generate short 
conversion tracts with one-sided and two-sided Gaussian distributions, respectively.  In 
the presence of compound genomic lesions such as DSBs and paired nicks, the SDSA 
pathway is preferentially utilized.  
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Results 
The EGFP > BFP conversion system 
To systematically investigate the molecular mechanism of meganuclease-induced 
PGE using ODN donors, we established the EGFP > BFP conversion system (Figure 
1A).  This system takes advantage of the sequence similarity of EGFP and BFP.  By 
introducing T65S and Y66H mutations into the chromophore domain, EGFP can be 
completely converted into BFP [171].  To this end, using recombinant adeno-associated 
virus (rAAV)-mediated PGE [129, 169], we introduced the CMV-EGFP-pA expression 
cassette into the HPRT locus on the X chromosome of human HCT116 cells, in both 
sense (S) and antisense (AS) directions with respect to the direction of the HPRT gene 
(Figures S2A and S2B).  Targeted integration in either direction results in mono-allelic 
EGFP expression and the inactivation of the HPRT gene.  After rAAV infection, the 
HPRT-negative cells were enriched using 6-thioguanine selection, and individual 
subclones with bright EGFP expression were screened using designated primers 
(Figures S2A and S2B).  The EGFP cassette was precisely knocked into the HPRT 
gene in 1 out of 4 subclones in the sense orientation and 2 out of 4 subclones in the 
antisense orientation (Figures S2C and S2D).  One individual subclone from each 
orientation was designated as HPRT-EGFP sense and antisense cell lines, respectively, 
and used for subsequent studies.  Targeted genomic lesions such as nicks and DSBs 
were subsequently introduced into these reporter cell lines within the chromophore 
sequence using Cas9 or nCas9 from S. pyogenes and sgRNAs in both sense (S) and 
antisense (AS) orientations with respect to EGFP (Figure 1A).  In the presence of ODN 
donors bearing the SH mutations (ACCTAC > TCTCAT), EGFP could efficiently be 
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converted into BFP, which generated distinguishable spectra under flow cytometry 
(Figure 1C and Figure S3B).   
The efficiency of ODN-mediated PGE 
We first determined the efficiency of ODN-mediated PGE using nCas9 with ODNs 
(BFP_S160 and BFP_AS160, see Supplemental Sequences for more details) and 
sgRNAs in both S and AS orientations with respect to EGFP (Supplemental 
Sequences).  By transfecting the HPRT-EGFP cell lines with the nCas9 and sgRNA 
expression vectors and ODN donors all in a DNA format, we could routinely induce 
efficient EGFP to BFP conversions as quantitated using flow cytometry (Figure 1 and 
Figure S3).  In contrast, the omission of the donor ODNs resulted in <0.01% conversion 
into blue cells (data not shown).  Interestingly (see the Discussion for additional 
discussion of this topic), the conversion frequency in the HPRT-EGFP antisense cell line 
was routinely 2 to 4 times higher than compared to the conversion frequency in the 
HPRT-EGFP sense cell line (Compare Figure 1 with Figure S3).  Because the HPRT-
EGFP antisense cell line consistently generated a higher BFP conversion efficiency, this 
cell line was chosen for subsequent studies.  In contrast to the bias observed with 
HPRT-EGFP orientation, the difference in conversion efficiency between any of the four 
possible sgRNA and ODN pair configurations was trivial with an average of ~1.5% 
conversion (Figure 1B, white bars).  Thus, no significant strand bias for either the nick 
or the ODN donor was observed and this was also true for the HPRT-EGFP sense cell 
line (Figure S3A).   
We next examined the efficiency of ODN-mediated PGE in the presence of double-
strand genomic lesions in the HPRT-EGFP antisense cell line.  Wildtype Cas9 cleavase 
and nCas9 paired-nickases [172-174] generate double-stranded blunt or sticky 
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overhangs, respectively.  Depending on the orientations of the protospacer adjacent 
motif (PAM) sequences, paired-nickases are generally classified into PAM-out and PAM-
in configurations, which generate 5’ and 3’ overhangs, respectively.  Impressively, all of 
the double-stranded genomic lesions induced PGE with consistently higher efficiency 
(~2-fold) than single nicks (Figure 1B, compare filled bars with white bars).  The only 
exception to this observation was in the case of the dual nickases utilizing PAM-in 
sgRNAs and AS donor ODNs, which had a conversion frequency more comparable to 
that induced by single nicks.  As we discuss below, this configuration is indeed a special 
case.  In summary, these experiments demonstrated that both nicks and (even more so) 
double-stranded lesions can induce robust PGE in human somatic cells by utilizing 
donor ODNs. 
The mechanisms of single-nick-induced PGE using complementary strand ODNs 
To map the associated conversion tracts, some of the ODNs were labeled with 
three-to-a-side synonymous single-nucleotide polymorphisms (SNPs) on both sides of 
the TY > SH mutations in either a distributive or clustered fashion (6SNPs_A and 
SNPs_B, respectively) in both S and AS orientations (Figures 1A, 2F and 
Supplemental Sequences).  The BFP-positive cells were enriched using FACS sorting 
and single-cell subcloned via limiting dilution.  The BFP conversion of the individual 
subclones was subsequently confirmed by PCR using mismatch sensitive primers 
(BFP_CF and BFP_ER, Supplemental Sequences).  The individual conversion tracts of 
the BFP-positive subclones were then amplified using flanking primers (BFP_EF and 
BFP_ER, Supplemental Sequences) and sequenced using Sanger sequencing 
(Tables S1-9).  The SNP retention curves were compiled by plotting the frequency of 
SNP retention against the distance of each SNP to the center of the SH mutations.  The 
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retention frequency of SNPs on both the 6SNP_A and 6SNP_B ODNs in the same 
configuration were overlaid into a single SNP retention curve (Figures 2 and 4). 
In contrast to dsDNA donors containing a long central heterology [169], ODNs-
mediated PGE produced short conversion tracts with Gaussian distributions (Figures 
2A-E).  When PGE was initiated by nCas9 and a single sgRNA, ODNs complementary 
to the strand with the nick produced conversion tracts with a ~one-sided Gaussian 
distribution biased in the 3’ direction relative to the nick (Figure 2A).  Impressively, the 
distribution of the conversion tracts was almost perfectly mirrored when the 
strandedness of the nick and the ODNs were simultaneously inverted (Figure 2B and 
Table S2).  In both cases, the SNP retention curve was composed of a mini plateau 
(very high co-conversion region) near the SH mutations being selected for, followed by a 
sigmoidal decay in the 3’ direction, and a steep drop-off in the 5’ direction.  For example, 
CAC, as the first SNP on the 6SNP_A ODN 3’ to the nick, was retained in 46.5% of the 
conversion tracts, whereas GTC, its counterpart 5’ to the nick, was converted a mere 2.3% 
of the time (Figure 2A and Table S1).  The corresponding SNPs on the 6SNP_B ODNs 
were converted with a similar asymmetry, although not always as dramatically as the 
ones on 6SNP_A.  This was probably due to the fact that the SH mutations and the 
proximal SNPs were clustered tightly together and therefore were frequently recognized 
as one piece of heterology during gene conversion.  The co-conversion of this larger 
heterology perforce utilized more distal homologies and generated longer conversion 
tracts. 
The conversion tracts generated by ODNs complementary to the strand with the 
nicks (Figure 2A, 2B) were consistent with an SDSA model [31-33], in which gene 
conversion stems from unidirectional DNA synthesis using the ODN sequence as a 
template [40] (Figure 3A, top).  After a genomic lesion such as a single-strand nick is 
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introduced, the 3’ strand of the lesion base pairs with the homology region on a 
complementary-strand ODN during homology search.  Then the invading strand copies 
the downstream genetic information from the ODN donor via 5’ to 3’ DNA synthesis.  
Interestingly, if a small part of the selected knock-in mutations are upstream (i.e., 5’) to 
the genomic lesion (as 4 or 5 nts are in our system), the 3’-end of the invading strand 
needs to be resected to accommodate the conversion of the heterology region before 
DNA synthesis begins.  Because we need to select for the conversion of the SH 
mutations and use proximal SNPs to map the conversion tracts nearby (which favors co-
conversion) in our experimental strategy, it is hard to address how often this 3’ end 
processing occurs in natural HDR where these constraints would not apply.  Whatever 
the frequency, however, it nevertheless seems that the 3’ end processing rarely goes 
beyond 10 bp (Figures 2A, 2B and 3A).  Then DNA synthesis proceeds past the knock-
in mutations before the invading strand anneals back with its original partner.  If DNA 
synthesis travels beyond the genomic lesion, a flap will be created after annealing.  The 
flap can be cleaved by structure-specific endonucleases and the resultant gap filled by 
DNA synthesis and ligation as part of the standard flap metabolism [175].  In summary, 
part of the ODN sequence including the knock-in mutations will be converted as a result 
of DNA synthesis starting from up to 10 bp 5’ of the genomic lesion (Figures 2A, 2B and 
3A, bottom).  Since the synapse formed by strand invasion cannot be stabilized by the 
formation of double Holliday junctions, the invading strand falls back quickly after DNA 
synthesis bridges the genomic lesion [21], generating short conversion tracts with an 
average of 20 bp in the 3’ direction (Figures 2A, 2B and 3A, bottom). 
  87 
The mechanisms of single-nick-induced PGE using same strand ODNs 
In contrast to ODN donors corresponding to the complementary strand, ODN 
donors corresponding to the same strand that was nicked produced short conversion 
tracts with more symmetrical two-sided Gaussian distributions (Figures 2C and 2D).  
For example, CAC, the first SNP in the 5’ direction on the 6SNP_A ODN, was retained 
20.5% of the time as compared to 31.8% for GTC, the corresponding first SNP in the 5’ 
direction (Figure 2C and Table S3).  Again, this SNP retention curve was mirrored when 
the strandedness of the nick and the ODNs were simultaneously inverted (Figure 2D 
and Table S4).  We also noted a modest, but consistent, 5’ bias in these SNP retention 
curves, in which the SNPs 5’ to the nick were consistently converted with higher 
frequency than their downstream counterparts (Figures 2C and 2D).  Interestingly, this 
bias is opposite to the direction of common exonuclease resection [176]. 
The bidirectional conversion tracts generated by ODNs same to the strand with the 
nicks were consistent with an ssDI model, in which the ODN is physically assimilated 
into a single-strand gap and displaces the flanking sequences on both sides [38-40] 
(Figure 3B).  Although various forms of the ssDI model have been previously proposed 
[72-76], the efficiency of this pathway was so low in the absence of targeted genomic 
lesions that it was generally not regarded as a naturally-occurring HDR pathway (also 
note that ssDI is different from the more familiar process of single-strand annealing; SSA) 
[7, 21].  Interestingly, it was suggested that transcript-RNA-mediated HDR occurs via a 
mechanism similar to ssDI, although the RNA donor has to fall off after it bridges the 
complementary strand genomic lesion [44].  In the presence of targeted genomic lesions, 
it was also not known how the lesions were processed into the single-stranded gaps 
required for ssDI.  In our model (Figure 3B), we propose that the initial gap is generated 
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by futile homology search when the 3’-end is trying to engage in the strand invasion ala 
the SDSA pathway (Figure 3A).  When the ODN is initially assimilated into the gap 
generated by a futile homology search, it will produce the subtle 5’ asymmetry/bias that 
was actually observed in our SNP retention curves (Figures 2C and 2D).  Bidirectional 
conversion tracts are then generated as the ODN displaces the flanking sequences via a 
branch migration-like activity [159], while 5’ to 3’ exonuclease resection may also 
contribute to this process [176].  Eventually, the flaps of the ODN and genomic DNA are 
processed by flap endonucleases [175], and the ODN are physically incorporated into 
the chromosome in both directions from the genomic lesions with a bias towards the 5’ 
direction from the lesion.  
The mechanism of DSB-induced PGE using ODN donors 
Double-stranded genomic lesions can theoretically engage both the SDSA and 
ssDI pathways in the presence of ODN donors.  To elucidate the hierarchy of HDR 
pathways utilized in the presence of double-strand genomic lesions, we first compiled 
the SNP retention curve of ODN-mediated PGE induced by wildtype Cas9 cleavase.  
When a DSB was introduced by Cas9, it generated a conversion tract with a ~one-sided 
Gaussian distribution (Figure 2E) that was virtually indistinguishable from the conversion 
track generated by a single-strand nick in a strand complementary to the ODN 
(compare Figure 2E, Table S5 with Figure 2A, Table S1).  The ~unidirectional 
conversion tracts indicated that, in the presence of a blunt-ended DSB directly at the 
position of the knock-in mutation, PGE is preferentially mediated by the SDSA pathway 
using the lesion complementary to the strand with the ODNs (Figure 3A), even though 
the lesion can likely initiate effective ssDI as well.  This result nicely explains a previous 
paradox that the physical incorporation of ODN donors was detected in the absence [38], 
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but not presence [79], of targeted chromosomal DSBs: without a targeted lesion, the 
ODNs were likely physically incorporated via the ssDI pathways [72-76] using naturally 
occurring gaps, whereas with a DSB most of the PGE products are generated via the 
SDSA pathway as a result of DNA synthesis using ODNs as templates (Figures 2E and 
3A). 
The mechanism of paired-nick-induced PGE using ODN donors 
The use of nCas9 in conjunction with dual sgRNAs in PAM-out and PAM-in 
configurations generates paired nicks with 5’ or 3’ overhangs, respectively [172-174].  
These overhangs can theoretically engage the ODNs via both the SDSA and ssDI 
pathways.  In addition, since paired nicks can be effectively placed up to 60 bp away 
from each other, it was not known whether they are processed into double-strand gaps.  
To illustrate the mechanisms of paired-nick-induced PGE, we compiled the SNP 
retention curves using nCas9 paired-nickases in both PAM-out and PAM-in 
configurations in the presence of S and AS ODN donors.  We discovered that these 
paired-nickases generated conversion tracts with much larger plateaus (Figure 4), 
compared to those of the respective single nicks (Figure 2).  The SNPs between the 
paired nicks were retained with an average of more than 75% frequency (Tables S6, S7).  
Besides the plateau, the PAM-out paired-nickases generated a one-sided SNP retention 
curve with a ~sigmoidal decay on the left, and a much steeper drop-off on the right 
(Figure 4A), whereas the PAM-in configuration with a S ODN donor generated two 
~sigmoidal curves (Figure 4B) that were farther apart from each other, compared to the 
SNP retention curve of the corresponding single nickase (Figure 2D).   
We propose that the 5’-overhangs generated by PAM-out paired-nickases can be 
processed by extensive exonuclease resection [176] to generate large double-stranded 
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gaps (Figure 5A) that ultimately yield the broad plateaued SNP retention curve (Figure 
4A).  We believe that, following this resection, PGE is likely initiated by strand invasion 
of a now uncovered 3’-end complementary to the strand of the ODNs via the SDSA 
pathway (Figure 5A).  In the PGE products, DNA synthesis would have to travel a long 
distance to bridge the extended double-strand gaps.  After annealing with the 3’ end on 
the other side of the lesion, the resultant flap on the AS strand is processed and single-
strand gap on the S strand is filled in by standard gap repair.  We believe that the steep 
drop-off on the right side of the SNP retention curve (Figure 4A) is an SDSA SNP 
retention signature (Figure 2A, 2B) indicative of the minimal 3’ end processing before 
the start of DNA synthesis, and that strand invasion is initiated by the 3’ overhang on the 
AS strand (Figure 5A).  The broad plateaued conversion tracts (Figure 4A) are thus 
evidence that the 5’ overhangs of the PAM-out paired-nickases are processed into 
double-strand gaps, so that the subsequent DNA synthesis has to travel beyond these 
gaps to repair the genomic lesions in the PGE products (Figure 5A). 
In contrast, in the PAM-in configuration, the 3’-overhangs initially generated by 
paired nicking are not subject to extensive exonuclease resection [176] (Figure 5B).  
Because the 3’ overhang on the AS strand complementary to the ODNs cannot 
effectively convert the knock-in mutations (unless it is resected by > 30 nts), the majority 
of the PGE products must be generated by the ssDI pathway.  We propose that the 
presence of AS strand nicks may loosen the 3’-ends on the chromosomal S strand and 
mobilize it for a (in this instance, futile) homology search (Figure 5B).  This would 
provide a window of opportunity for the S strand ODN to anneal to the gap generated by 
futile homology search before further bidirectional strand displacement occurs.  In total, 
this would produce the longer conversion tracts observed compared to those of single-
nick-induced PGE via the ssDI pathway (compare Figures 2D and 4B). 
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The hierarchy of ODN-mediated PGE in the presence of compound genomic 
lesions 
For the paired-nickase-induced PGE using S strand ODNs, we notice that the 
knock-in mutations and 3’ overhang on the AS strand are close to each other in the 
PAM-out configuration, but far away in the PAM-in configuration (Figures 4A and 4B).  
Even if SDSA is the preferred pathway for double-strand lesions (Figure 2E), it cannot 
effectively convert the knock-in mutations using the AS strand overhang in the PAM-in 
configuration, unless extensive resection of the 3’-end occurs (Figure 4B).  To dissect 
whether the hierarchy of paired-nickases-induced PGE is determined by the PAM 
configuration or the relative position of the knock-in mutation and the 3’ overhang on the 
complementary strand, we also compiled the SNP retention curves of paired-nickases-
induced PGE using AS strand ODNs (Figures 4C and 4D).   
PAM-out paired-nickases with AS strand ODNs produced a compound SNP 
retention curve with a plateau, a sigmoidal decay on the right and a linear slope on the 
left side (Figure 4C and Table S8).  We inferred that the conversion tracts were 
predominantly generated by ssDI, because SDSA would have produced continuous 
conversion tracts downstream of the 3’ overhang on the S strand (and thus ACC, TCC 
and CAC would have been retained with 100% frequency — which was not observed).  
We thus propose that the 5’ overhangs generated by PAM-out paired-nickases are first 
resected by exonucleases [176] to expose a single-strand gap for ssDI (Figure 6A).  
Since resection on both strands may occur to a random extent before an incoming ODN 
is assimilated to the 5’ overhang on the S strand, the left border of the single-strand 
gaps should be randomly distributed within a certain region before the initial ssDI occurs.  
Subsequently, strand displacement occurs in both directions, which creates the sigmoid 
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decay on the right of the SNP retention curve.  At the same time, the linear slope on the 
left is shaped by the accumulation of individual ssDI events with random left borders 
(Figures 4C and 6A, bottom). 
On the other hand, PAM-in paired-nickases generated a two-sided SNP retention 
curve (Figure 4D) similar to that of single-nick-induced ssDI (Figure 2C).  We propose 
that the bulk of the PGE products are generated via a simple SDSA process initiated by 
the 3’-overhang on the genomic S strand (Figure 6B). However, the conversion tracts 
were slightly wider than those from single-nick-induced SDSA (Tables S2 and S9), 
probably because the 3’ overhang on the S strand exceeds the first nucleotide of the SH 
mutations by 7 bp (Figure 4D and Supplemental Sequences), which may lead to 
reduced gene conversion efficiency due to the requirement for relatively extensive end 
resection.  As a result, some PGE products may also stem from the ssDI pathway using 
the nick on the AS strand, which may contribute to the higher SNP retention frequency 
on the left side (Figure 4D) than is seen in a exclusively SDSA-dependent profile 
(Figure 2B).  Finally, steric hindrance of PAM-in paired-nickases [172-174] may also 
result in partial nicking in a fraction of cells; and a single nick on the AS strand would 
have to engage the ssDI pathway.  Consistent with all these notions, it is relevant to note 
that of all the compound lesions and donor ODN configurations analyzed the efficiency 
of BFP conversion in this PAM-in configuration was the lowest (Figure 1B). 
The physical incorporation of ODN donors in the ssDI pathway 
The distribution of conversion tracts can be complicated by 3’ processing and the 
co-conversion of proximal SNPs.  Besides the directionality of the conversion tracts, a 
definitive feature that distinguishes the SDSA and ssDI pathways is the physical 
incorporation of donor ODNs [38, 79].  Thus, the ODNs are physically incorporated to 
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bridge a genomic lesion in the ssDI pathway, whereas in SDSA, the genomic lesion is 
repaired by DNA synthesis using the ODN sequence solely as a template (Figures 3A 
and 3B).  To confirm the results of our conversion tract study, we internally labeled a T 
nucleotide with biotin in S strand ODNs in the center of the SH mutation (TCTCAT, 
Supplemental Sequences), and searched for the physical incorporation of this 
biotinylated T in the PGE products induced by nCas9, Cas9 and nCas9 paired-nickases 
(Figure 7).  Shortly after transfecting the HPRT-EGFP antisense cells with the 
designated Cas9 or nCas9, sgRNAs and the biotinylated ODNs, cells with bright BFP 
expression were isolated by FACS sorting.  The genomic DNA from 105 BFP positive 
cells was prepared, digested to completion with XhoI and XbaI restriction enzymes, and 
pulled down using streptavidin beads [38, 79] (Figures 7A and 7B).  The free and non-
covalently bond DNA fragments were carefully washed away under denaturing 
conditions, and the beads with covalently-linked fragments were used as templates in a 
40-cycle PCR reaction.  An internal primer and a flanking primer were used to 
specifically detect the ODNs targeted incorporated into the BFP locus (BFP_CF and 
BFP_QR, Supplemental Sequences).  Using biotinylated ODNs on the S strand, the 
covalently-linked genomic fragments were detected only with a single sgRNA on the AS 
strand and dual sgRNAs in the PAM-in configuration, but not with a single sgRNA on the 
S strand, a single sgRNA with wildtype Cas9 [79] and dual sgRNAs in the PAM-out 
configuration (Figure 7C).  Collectively, these results confirmed that the ODNs were 
physically incorporated into the chromosome only when the ssDI model was predicted 
by the conversion tract profiles (Figures 2D and 4B). 
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Discussion 
Our conversion tract and ODN incorporation studies not only establishes the 
properties of the individual SDSA and ssDI pathways, but also illustrates the hierarchy of 
ODN-mediated PGE mediated by double-stranded genomic lesions.  The SDSA and 
ssDI pathways have their respective effective conversion zones, as defined by the 
region with more than 50% conversion frequency with respect to the genomic lesion 
initiating the pathways (Figure 3, bottom, also see Figure 2).  Therefore, conversion of 
knock-in mutations is inefficient outside the conversion zones and this parameter should 
be considered when designing gene targeting studies.  Although both pathways work 
robustly by themselves (Figure 1B and Figure S2A), it appears that they don’t work 
additively in the presence of DSBs when both pathways are nonetheless in their 
effective zone [79] (Figures 2E and 7C).  Instead, SDSA is preferentially utilized 
whenever the knock-in mutation is within the effective zone of the 3’ overhang 
complementary to the strand with the ODN donors (Figures 2E and Figure 4).  This 
could be because cells tend to prevent the physical incorporation of exogenous 
sequences during HDR whenever possible.  However, when the SDSA pathway drops 
out of its effective zone, ssDI is capable of generating the majority of the PGE products 
(Figures 4B and 4C).   
Interestingly, double-stranded lesions generally induced PGE with a higher 
frequency than single-strand nicks (Figure 1B).  The only instance where a complex 
genomic lesion didn’t induce increased PGE was in the case of PAM-in paired-nickases 
using ODN donors from the AS strand (Figure 1B).  As elaborated above, this was also 
the only instance where extensive (> 7 nt) resection of the 3’-end was required for PGE 
to occur and we believe that these two observations are connected.  If this exception is 
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illustrative, it may suggest that double-strand lesions in general loosen the local 
chromosomal architecture more than single-strand nicks and thus permit relevant co-
factors (such as resection nucleases) easier access to the 3’-end and ultimately 
facilitating more vigorous homology searches. 
In our nick-induced PGE experiments, no significant strand bias for either the nick or 
the ODN donors was observed (Figure 1B).  These observations were consistent with a 
previous report using zinc-finger nickases at three independent chromosomal loci [177] 
but inconsistent with a more recent one [40].  The latter difference might be explained by 
the fact that the recent report employed ODN donors with a large (17 bp) heterology 
flanking the genomic lesion [40].  As discussed above, a sizable heterology on both 
sides of the genomic lesion would strongly favor the use of ssDI as a bidirectional gene 
conversion pathway.  In contrast, in order to be converted by the SDSA pathway, 3’ 
resection of at least 8 to 9 bp would be required and that likely occurs at a much lower 
frequency.  Collectively, these observations suggest that strand-specific transactions 
such as transcription and DNA replication are unlikely to have a major influence on PGE 
mediated by nicks.  With that said, it is important to note that while no strand-specific 
biases were noted in any of our experiments, a significant 2- to 4-fold higher frequency 
of PGE was noted for the BFP reporter in the anti-sense orientation than in the sense 
orientation (Figure 1 and Figure S3).  The reason for this bias is not completely clear, 
but it is unlikely to be due to conflicting transcription between the EGFP reporter and the 
endogenous HPRT locus because EGFP expression was very high in these cells.  
Indeed, we believe the bias was technical (and not biological) in nature since the higher 
EGFP (and consequently BFP) expression may have simply allowed us to more easily 
isolate correctly targeted cells. 
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PAM-in paired-nickases are significantly less effective in producing NHEJ-related 
mutations than their PAM-out counterparts, which has mainly been attributed to the 
steric hindrance of the nCas9 proteins in the PAM-in configuration and/or the 
displacement loops formed the by sgRNAs [172-174].  Our results may provide an 
additional or alternative explanation (Figure 5A and 6A): PAM-out paired-nickases 
generate 5’-overhangs that are subject to exonuclease resection [176].  The resection 
creates a double-strand gap that will normally engage the error-prone NHEJ pathway 
and produce deletions in between.  In contrast, the 3’ overhangs produced by PAM-in 
paired-nickases may remain largely as separated nicks (Figure 5B and Figure 6B), 
which may be precisely repaired by standard single-strand nick repair without engaging 
the NHEJ pathway.  Importantly, however, the PAM-in paired-nickases can induce PGE 
at a comparable efficiency to their PAM-out counterparts (Figure 1B), at least when the 
PAM sequences are placed far enough apart from each other to avoid steric hindrance.  
Thus, we propose that PAM-in paired-nickases are less efficient in NHEJ-mediated gene 
disruption because the 3’ overhangs rarely form double-strand gaps due to the lack of 3’ 
to 5’ resection [176].  Consequently, although PAM-in paired nickases are not often used 
for PGE, they may actually be advantageous because they may induce similar levels of 
HDR with less NHEJ mutations compared to their PAM-out counterparts. 
Although paired-nickases induced PGE with a higher frequency compared to a 
single nickase (Figure 1B), we noticed that paired-nickases (in both PAM configurations) 
occasionally produced imprecise HDR products using ODN donors (Tables S6-9).  Most 
of the imprecise products contained NHEJ-like mutations near the position of the distal 
nick with respect to the knock-in mutations.  Since a single nickase can also generate 
NHEJ mutations [40, 80], we propose that the imprecise HDR was generated by the 
repeated nicking of the distal nickase in the PGE products.  These mutations were not 
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found near the position of the proximal nicks because, in our system, the conversion of 
the knock-in mutations would destroy the binding site of the proximal nickase and 
prevent further nicking in the PGE products.  If this hypothesis is correct, an important 
guideline of ODN-mediated PGE would be to introduce an additional silent mutation in 
the PAM sequence of the ODN donors to prevent the further binding of Cas9 or nCas9 in 
the PGE products. 
Our conversion tract data also provides insight into a recent paradox: although 
SDSA is the more efficient form of meganuclease-induced HDR [126, 178], the majority 
of the PGE products are actually generated by the DSBR pathway when dsDNA donors 
with long central heterologies are employed [125, 126, 169, 179].  Our results and 
other’s demonstrate that SDSA is apparently a short-tract gene conversion pathway 
using chromosomal [180, 181] and ODN donors (Figures 2A and 2B).  Also, the 
Gaussian distribution nature of the associated conversion tracts makes it extremely 
inefficient in producing gene conversions longer than 100 bp (Figures 2A and 2B).  
Thus, dsDNA donors with long central heterologies would perforce engage a long-tract 
gene conversion pathway in the PGE products.  Notably, meganuclease-induced HDR 
using chromosomal donors occasionally generated unidirectional long-tract gene 
conversion products [180, 181], which were believed to be produced by break-induced 
replication (BIR) [34-36].  In the case of PGE, however, BIR using exogenous homology 
donors leads to the formation of chromosome-donor fusions and severely compromises 
genomic stability [34-36].  In contrast, our previous work demonstrated that the DSBR 
pathway is a second (and precise) long-tract gene conversion pathway [169], which 
generates bidirectional conversion tracts with a linear distribution.  Collectively, these 
results indicate that although SDSA is the more efficient HDR pathway for short-tract 
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gene-conversion, the DSBR pathway is the predominant pathway of PGE using dsDNA 
donors with long central heterologies. 
dsDNA donors can mediate robust PGE in our hand.  We can routinely achieve 
about 20% marker-free PGE using Cas9-2A-GFP with associated FACS enrichment 
[182] and circular dsDNA donors with long central heterology (data not shown).  As a 
practical guideline, we propose that circular dsDNA should be utilized in the presence of 
DSBs and/or paired-nicks for converting large knock-in mutations.  One of the reasons 
that these donors work so well is that they may have a longer half-life than ODN donors, 
which better coincides with the kinetics of the Cas9 expressed in a DNA format.  ODN 
donors should be utilized for converting small modifications.  Although ODN donors are 
optimally used for introducing SNPs, they can also be used to introduce more complex 
genomic lesions by producing slightly longer conversion tracts.  Regardless, what is 
critical is that the knock-in mutation(s) needs to be placed within the effective conversion 
zones of the SDSA or ssDI pathways, or it will not be incorporated into the genome.  
Cas9 expressed in mRNA or protein formats may be used to accommodate the shorter 
half-life of ODN donors and increase the efficiency of PGE. 
In conclusion, our studies have proved the SDSA and ssDI models of ODN-
mediated PGE [40] with two pieces of molecular evidence: the directionality of 
conversion tracts and the physical incorporation of the donor ODNs.  In contrast to the 
DSBR model [169], both pathways produce short conversion tracts with Gaussian 
distributions.  We also extended these observations to compound genomic lesions, and 
demonstrated that SDSA is preferentially utilized when the knock-in mutation lies within 
its effective conversion zone, whereas ssDI serves as a backup pathway.  The identity, 
property and hierarchy of these pathways should serve as general guidelines of donor 
design in any PGE experiment: dsDNA donors are required for introducing large knock-
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in mutations, whereas ODNs can conveniently convert small modifications; all the 
mutations have to be engineered within the effective conversion zones of the specific 
pathways.  These findings also advance our understanding of endogenous HDR-
mediated gene conversions, which, in turn, should shed light on potential improvements 
of PGE. 
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Figures and Legends 
 
Figure 1.  The EGFP > BFP conversion system in the HPRT-EGFP antisense cell 
line  
(A) Schematics of the EGFP > BFP conversion system in the HPRT-EGFP 
antisense cell line.  An EGFP expression cassette was knocked into the HPRT locus of 
the HCT116 cell line (only the antisense orientation is diagrammed here for the sake of 
ease of presentation).  Genomic lesions could then be introduced near the chromophore 
(TY residues) of the EGFP sequence using CRISPR/Cas9 cleavase, nickases or dual 
nickases.  HDR repair of the genomic lesions using ODN donors containing the 
sequence of the SH residues leads to the conversion of EGFP to BFP.  The ODN donors 
also contained synonymous SNPs that could be co-converted with the sequence of the 
SH residues.  Schematic elements: EGFP, green boxes; BFP, blue boxes; HPRT, 
inverted yellow boxes; sequences of the chromophore residues, CY and SH; the 
cytomegalovirus promoter, CMV; the polyadenylation sequence, pA; Cas9 variants, red 
ovals with scissors; genomic lesions, lightning bolts; ODN donors, horizontal red lines; 
synonymous SNPs, vertical blue hashmarks.  (B) The efficiency of BFP conversion in 
the HPRT-EGFP antisense cell line.  The wildtype Cas9 and D10A variant are labeled as 
Cas9 and nCas9, respectively.  The strandedness (S, sense; AS, antisense) of the 
sgRNA and ODNs (for this experiment without synonymous SNPs) are labeled with 
respect to the coding sequence of EGFP.  Note that the Cas9 D10A variant nicks the 
strand complementary to that of the sgRNA.  All data are shown as the mean ± SEM of 
three biological replicates.  (C) Single representative flow cytometry images of each bar 
shown in (B). 
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Figure 2.  Conversion tracts of single-nick and DSB-induced HDR using ODN 
donors   
(A-E) The conversion tracts of single-nick-induced HDR using ODN donors 
complementary to (A, B) or the same strand of (C, D) the nick, and DSB-induced HDR 
(E).  The conversion tracts were compiled by overlaying the retention frequency of each 
SNP in both 6SNP_A and 6SNP_B donors.  The positions of the SNPs and predicted 
genomic lesions are labeled in reference to the center of the chromophore sequence.  
Schematic elements are colored as follows: genomic DNA, black; genomic lesions, 
orange; ODNs, red; chromophore sequences, TY and SH; SNPs on the 6SNP_A ODNs, 
blue; SNPs on the 6SNP_B ODNs, green; homology regions, dashed silver crosses; 
strandedness of DNA, S and AS.  (F) Schematics of the ODN donors with synonymous 
SNPs.  The SNPs are represented as the central nucleotide of the tri-nucleotides in the 
S orientation, and the distance between the SNPs and the center of the SH sequence 
(TCTCAT) is labeled.  Because the last T in the SH sequence is a wobble nucleotide it 
could be used as SNP as well and is represented as the ATG at position +3.  ODNs with 
six distributed or clustered SNPs are labeled as 6SNP_A (A) and 6SNP_B (B), 
respectively.  The sequences shown at the bottom of the panel emphasize that the S 
nick is made at position -1 and the AS nick at position -2.  The actual sequences of the 
ODNs can be found in Supplemental Sequences. 
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Figure 2A-D 
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Figure 2E-F 
 
 
  
  105 
 
Figure 3.  Mechanisms of single-nick-induced PGE using ODN donors 
(A) Repair of complementary strand nicks via SDSA.  (B) Repair of nicks on the 
same strand via ssDI.  Schematic elements are labeled as follows: Top — genomic DNA, 
black; genomic lesions and DNA ends, hatched orange lines; ODNs, red; knock-in 
mutations, green; resection nucleases, yellow PAC ManTM; base pairing, purple vertical 
lines; DNA synthesis, red dashed arrows; processing nucleases, yellow lightning bolts; 
Bottom — predicted SNP retention curves, red dashed line; predicted position of 
genomic lesions, orange vertical dashed line; position of the knock-in mutation selected 
for, green vertical solid line; regions with more than 50% co-conversion frequency, black 
double-headed arrows, strandedness of DNA, S and AS; orientations of the DNA ends, 5’ 
and 3’. 
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Figure 4.  The conversion tracts of paired-nicks-induced HDR and the physical 
incorporation of ODN donors 
(A-D) The conversion tracts of paired-nicks-induced HDR using S (A, B) and AS 
ODNs (C, D).  The conversion tracts were compiled by overlaying the retention 
frequency of each SNP in both 6SNP_A and 6SNP_B donors (Figure 2F).  The 
positions of the SNPs and predicted genomic lesions are labeled in reference to the 
center of the chromophore sequence.  All schematic elements are colored as in the 
legend of Figure 2.   
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Figure 5.  Mechanisms of paired-nick-induced PGE using the S ODNs 
(A) Repair of the PAM-out double nicks via SDSA.  (B) Repair of the PAM-in 
double nicks via ssDI.  All schematic elements are colored and defined as in the legend 
to Figure 3. 
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  111 
 
Figure 6.  Mechanisms of paired-nick-induced PGE using the AS ODNs 
(A) Repair of the PAM-out double nicks via ssDI.  (B) Repair of the PAM-in double 
nicks via SDSA.  All schematic elements are colored and defined as in the legend to 
Figure 3. 
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Figure 6 
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Figure 7.  The biotin pull-down assay 
(A, B) Schematic illustration of the biotin pull-down assay via the SDSA (A) and 
ssDI (B) pathways.  In the case of ssDI (A) the biotinylated ODN is predicted to be 
incorporated into the target genomic locus whereas in SDSA (B) it should not.  The XhoI 
and XbaI digested genomic fragments covalently linked to biotin can be enriched using 
streptavidin beads under denaturing conditions.  The primers BFP_QF and BFP_QR can 
specifically amplify these genomic fragments with ODN incorporation but not free ODN 
donors.  Biotin, yellow circle; streptavidin, orange ovals; genomic DNA, black lines; ODN 
sequence, solid red lines; DNA synthesis, dashed red lines; chromophore sequence, TY 
and SH; genomic lesions, hatched yellow lines; homology regions, dashed silver crosses; 
restriction sites, XhoI and XbaI; PCR primers, horizontal arrows.  (C) Results of the 
biotin pull-down assay.  After transfecting with biotinylated ODNs (BFP_S90_Biotin, 
Supplemental Sequences), the BFP-positive cells were enriched using FACS sorting.  
The genomic DNA of the BFP-positive cells was digested with XhoI and XbaI.  The 
fragments covalently linked to biotin were pulled down with streptavidin beads in 
denaturing conditions, PCR amplified using one internal primer and one flanking primer 
of the ODN donors (BFP_QF and BFP_QR, Supplemental Sequences) and detected 
on an agarose gel. 
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Figure S1.  Schematics of the HDR pathways leading to PGE 
(A) Synthesis-dependent strand annealing.  (B) Single-strand DNA incorporation.  
(C) Double-strand break repair (aka, the Szostak model).  (D) Holliday junction 
dissolution.  Schematic elements are colored as follows: genomic DNA, black; genomic 
lesions, hatched orange lines with yellow lightning bolts; ODNs, red; knock-in mutations, 
green; base-pairing, vertical purple lines; DNA synthesis, dashed arrows; strandedness 
of DNA, S and AS. 
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Figure S2.  Construction of the HPRT-EGFP cell lines 
(A) The HPRT-EGFP sense cell line.  (B) The HPRT-EGFP antisense cell line.  
The CMV-EGFP-pA cassette was targeted to replace exon 3 of the HPRT gene in either 
sense or antisense direction in respect to HPRT using rAAV-mediated gene targeting.  
Targeted cells were enriched with 6-thioguanine selection and screened using the 
designated primer pairs (Supplemental sequences).  HPRT, hypoxanthine-guanine 
phosphoribosyltransferase; HA, homology arms; CMV, the cytomegalovirus promoter; 
pA, the polyadenylation sequence, hairpins, inverted terminal repeats. 
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Figure S3.  The efficiency of BFP conversion in the HPRT-EGFP sense cell line 
(A) The efficiency of BFP conversion.  The wildtype Cas9 and D10A variant are 
labeled as Cas9 and nCas9, respectively.  The strandedness of the sgRNA and ODNs 
(without synonymous SNPs) are labeled with respect to the coding sequence of EGFP.  
Note that the Cas9 D10A variant nicks the strand complementary to that of the sgRNA.  
All data are shown as the mean ± SEM of three biological replicates.  (B) Single 
representative flow cytometry images of each bar shown in (A).  The medians of three 
biological replicates are shown. 
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Tables S1-9.  Individual conversion tracts of single nick- (S1-4), DSB- (S5) and 
paired-nick- (S6-9) induced PGE using ODN donors 
Top — Schematic configurations of PGE.  Genomic DNA, black; genomic lesions, 
hatched orange lines; chromophore sequences, TY and SH; ODNs, red; SNPs on the 
6SNP_A ODNs, blue; SNPs on the 6SNP_B ODNs, green; homology regions, dashed 
silver crosses; strandedness of DNA, S and AS.  Bottom — SNP retention of individual 
conversion tracts.  SNP, center of the trinucleotides; TCTCAT, the SH sequence; 
retained SNPs, +; lost SNPs, -; retained SNPs on the 6SNP_A ODNs, blue; retained 
SNPs on the 6SNP_B ODNs, green; number of inserted nucleotides near the designated 
SNPs, Ins #; number of deleted nucleotides near the designated SNPs, del #. 
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Table S1.  Conversion tracts of nick-induced HDR using S sgRNA* and S ODNs 
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Table S2.Conversion tracts of nick-induced HDR using AS sgRNA*and AS ODNs 
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Table S3. Conversion tracts of nick-induced HDR using S sgRNA* and AS ODNs 
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Table S4. Conversion tracts of nick-induced HDR using AS sgRNA* and S ODNs 
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Table S5. Conversion tracts of DSB-induced HDR using AS sgRNA and S ODNs 
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Table S6. Conversion tracts of PAM-out paired-nick-induced HDR using S ODNs 
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Table S7. Conversion tracts of PAM-in paired-nick-induced HDR using S ODNs 
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Table S8.Conversion tracts of PAM-out paired-nick-induced HDR using AS ODN 
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Table S9. Conversion tracts of PAM-in paired-nick-induced HDR using AS ODNs 
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Supplemental Sequences  
The EGFP reporter cell lines 
CMV-EGFP-pA: 
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTC
CGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCC
GCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCC
ATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAA
GTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGC
CTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTA
CGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGC
GTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAAT
GGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCC
GCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCA
GAGCTGGTTTAGTGAACCGTCAGATCCGCTAGCGCTACCGGACTCAGATCTCGAG
CTCAAGCTTCGAATTCTGCAGTCGACGGTACCGCGGGCCCGGGATCCACCGGCCG
GTCGCCACCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATC
CTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAG
GGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCG
GCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCA
GTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCA
TGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTA
CAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGA
GCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAG
TACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCAT
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CAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCC
GACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACA
ACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGA
TCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGAC
GAGCTGTACAAGTAAAGCGGCCGCGACTCTAGATCATAATCAGCCATACCACATTT
GTAGAGGTTTTACTTGCTTTAAAAAACCTCCCACACCTCCCCCTGAACCTGAAACAT
AAAATGAATGCAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGTTACAAAT
AAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTG
TGGTTTGTCCAAACTCATCAATGTATCTTAAG 
 
PCR primers for the HPRT homology arms.  Only annealing sequences of the 
primer tails are shown: 
HPRT_left_forward (HPRT_LF): CATGTTTGGTACTTGTTCAGC 
HPRT_left_reverse (HPRT_LR): TTAGCCAGGCATGGTAGC 
HPRT_right_forward (HPRT_RF): ACTAGTCACCTTGGAGGATAT 
HPRT_right_reverse (HPRT_RR): CAAAGCATTTCTACCACTCAG 
 
Screening primers: 
HPRT_external_forward (HPRT_EF): AGTATCAGTTGTGGTATAGTGG 
EGFP_internal_reverse (EGFP_IR): GGTGGTGCAGATGAACTT 
EGFP_internal_forward (EGFP_IF): CGACAACCACTACCTGAG 
HPRT_external_reverse (HPRT_ER): ATCAGTTGAGGAGTTCAGC 
 
The EGFP-BFP conversion 
sgRNA sequences: 
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GFP_S: CTCGTGACCACCCTGACCTA 
GFP_AS: GCACTGCACGCCGTAGGTCA 
GFP_PAMout_S: CTCGTGACCACCCTGACCTA 
GFP_PAMout_AS: CCAGGGCACGGGCAGCTTGC 
GFP_PAMin_S: CCGGCAAGCTGCCCGTGCCC 
GFP_PAMin_AS: GCTGAAGCACTGCACGCCGT 
 
ODN donors: 
BFP_S160: 
ACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTG
GCCCACCCTCGTGACCACCCTGTCTCATGGCGTGCAGTGCTTCAGCCGCTACCCC
GACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTA 
BFP_AS160: 
TAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTGCTTCATGTGGTCGGGGT
AGCGGCTGAAGCACTGCACGCCATGAGACAGGGTGGTCACGAGGGTGGGCCAGG
GCACGGGCAGCTTGCCGGTGGTGCAGATGAACTTCAGGGTCAGCTTGCCGT 
BFP_S160_6SNP_A (S_6SNP_A): 
ACGGCAAGCTGACCCTGAAATTCATCTGCACCACCGGCAAACTGCCCGTGCCCTG
GCCCACACTCGTGACCACCCTGTCTCATGGCGTGCAGTGCTTCAGTCGCTACCCC
GACCACATGAAACAGCACGACTTCTTCAAGTCTGCCATGCCCGAAGGCTA 
BFP_S160_6SNP_B (S_6SNP_B): 
ACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTCCCCTG
GCCCACCCTCGTCACCACGCTGTCTCATGGCGTCCAGTGTTTCAGCCGCTACCCT
GACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTA 
BFP_AS160_6SNP_A (AS_6SNP_A): 
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TAGCCTTCGGGCATGGCAGACTTGAAGAAGTCGTGCTGTTTCATGTGGTCGGGGT
AGCGACTGAAGCACTGCACGCCATGAGACAGGGTGGTCACGAGTGTGGGCCAGG
GCACGGGCAGTTTGCCGGTGGTGCAGATGAATTTCAGGGTCAGCTTGCCGT 
BFP_AS160_6SNP_B (AS_6SNP_B): 
TAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTGCTTCATGTGGTCAGGGT
AGCGGCTGAAACACTGGACGCCATGAGACAGCGTGGTGACGAGGGTGGGCCAGG
GGACGGGCAGCTTGCCGGTGGTGCAGATGAACTTCAGGGTCAGCTTGCCGT 
BFP_S90_Biotin: 
CACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGTC/iBiodT/C
ATGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAA 
 
PCR primers:  
BFP_external_forward (BFP_EF): CACAAGTTCAGCGTGTCC 
BFP_external_reverse (BFP_ER): GGTGCTCAGGTAGTGGTT 
BFP_confirmation_forward (BFP_CF): CCACCCTGTCTCATGGC 
BFP_quantification_reverse (BFP_QR): TGTGGCTGTTGTAGTTGTA 
 
  
  135 
Materials and Methods 
Nucleotide sequences 
All sgRNA targets, ODN donors, primers and the relevant plasmid sequences can 
be found in Supplementary Sequences. 
Cell culture 
The human HCT116 cell line was cultured in McCoy’s 5A medium supplemented 
with 10% FBS, 1% L-glutamine, 1% penicillin/streptomycin with 5% CO2 at 37 oC.   
The HPRT-EGFP cell lines 
The rAAV EGFP knock-in vectors were constructed using an unpublished method 
(Kan et al., manuscript in preparation).  Basically, the CMV-EGFP-pA cassette was 
amplified from EGFP-N2 (Clontech), and the homology arms flanking HPRT exon 3 were 
amplified using designated primers (Supplementary Sequences).  The CMV-EGFP-pA 
cassette and homology arms are ligated into a modified version of the pAAV-MCS vector 
in both sense and antisense orientations with respect to HPRT.  rAAV packaging and 
infections were performed as described [183].  The infected HCT116 cells were seeded 
into 10 cm tissue culture dishes and selected with 5 µg/mL 6-TG for 14 days.  Individual 
colonies were initially scanned for EGFP expression under a fluorescence microscope, 
and subsequently screened by PCR using the indicated primers (Figure S2A, S2B).  
One of the targeted clones with EGFP in either sense or antisense directions in the 
HPRT locus were flow sorted for high EGFP expression using a FACSAria II cell sorter 
(BD Biosciences) and used for subsequent studies. 
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The EGFP > BFP conversion 
The EGFP reporter cells were seeded at ~50% confluency.  The next day, 5 x 105 
cells were transfected with the Cas9 or nCas9 expression plasmid (10 µg; #41815 and 
#41816, Addgene), the MLM3636 plasmid containing designated sgRNA expression 
cassette (10 µg; #43860, Addgene) and the relevant ODNs (10 µg) using a Neon 
Transfection System (Invitrogen).  For paired-nickases, cells were transfected with 7.5 
µg of each sgRNA plasmid, the Cas9 expression plasmid and ODNs.  All transfections 
were performed using 100 µL tips under elevated conditions compared to the 
manufacturer’s protocol: 1530V, a 10 msec pulse width, and 3 pulses.  For the PGE 
efficiency experiment, cells were transfected using ODNs without flanking SNPs 
(Supplementary Sequences), and the percentage of BFP positive cells were 
quantitated 2 days after transfection using a LSRFortessa cell analyzer (BD 
Biosciences).  For the conversion tracts experiment, cells were transfected using ODNs 
containing flanking SNPs.  Cells from 5 individual transfections were combined, cultured 
for 2 days and sorted for BFP expression using a FACSAria II cell sorter (BD 
Biosciences). 
Conversion tracts analysis 
The BFP positive cells were single-cell subcloned into 96-well-plates at a 
concentration of 3 to 10 cells per well.  14 days later, single colonies were trypsinized, 
transferred into new 96-well plates and grown to confluency.  Genomic DNA was 
prepared using DirectPCR Lysis Reagent (Viagene).  The BFP fragments containing all 
the potential SNPs were amplified and confirmed by PCR using primers BFP_EF X 
BFP_ER and BFP_CF X BFP_ER, respectively.  The PCR products were purified using 
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a Qiaquick PCR purification kit.  The retention of vector-borne SNPs was analyzed by 
Sanger sequencing. 
The biotin incorporation assay 
The biotin incorporation assay was performed as described [38] with minor 
modifications.  The EGFP reporter cells were transfected with internal biotin-labeled 
ODNs (BFP_S90_Biotin) and flow sorted as described above.  The genomic DNA from 1 
x 105 BFP-positive cells was prepared using a Puregene Cell kit (Gentra) with a 60 min 
centrifugation step after isopropanol precipitation.  The genomic DNA was digested to 
completion with XhoI and XbaI restriction enzymes (New England Biolabs).  The 
biotinylated DNA fragments were isolated using a Dynabeads Kilobase BINDER kit (Life 
Technologies) according to manufacturer’s protocol, except that all reagents were 
supplemented with 0.1% BSA, and two additional washes using 0.1 M NaOH and 0.05 M 
NaCl at room temperature and one more rinse with 95 oC water were performed to 
remove the non-covalently linked genomic fragments.  The biotinylated genomic 
fragments were detected with a 40-cycle PCR using Phusion Hot Start II High-Fidelity 
DNA polymerase (Thermo Scientific).  The genomic DNA preparation prior to 
Dynabeads purification was used as control in a 25-cycle reaction. 
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Conclusions 
Since CRISPR/Cas9 was repurposed for genome engineering in 2013 [56-60], it 
has quickly swept through the laboratories around the world and caused a major 
upheaval in biomedical research [94-99].  For the first time, scientists are able to 
engineer, in principle, any part of the human genome with extreme ease and precision.  
If we compare the human genome to an encyclopedia with 24 volumes (unique 
chromosomes), ~20,000 chapters (genes) and 3,200,000,000 letters (base pairs), the 
CRISPR/Cas9 induced PGE technique allows us to edit any individual letters in a given 
chapter without making any spelling errors [49].  In laboratories, the “CRISPR Craze” is 
quickly bridging the genotype and phenotype worlds in reverse genetics studies.  It 
allows geneticists to scrutinize every building block of our genomes and introduce 
intentional alterations to our genetic materials that are otherwise only accessible to 
Mother Nature.  In clinics, CRISPR/Cas9 holds promise to revolutionize the treatment of 
a wide range of incurable diseases and viruses such as cancer and HIV, and inherited 
disorders such as sickle-cell anemia, Down syndrome and Huntington’s disease.  This 
technique is hailed as a landmark in biological research among the most famous 
technological platforms such as PCR, RNAi and iPS cells, and a milestone in biomedical 
science [49, 97, 99]. 
Interestingly, CRISRP/Cas9 does not perform PGE by itself, but it only induces a 
targeted genomic lesion and invites the HDR pathways to introduce the desired 
modifications to the genome [12].  Although HDR is relatively well studied in yeast and 
human cells [6, 7, 14, 20, 37], the identity, property and hierarchy of the HDR pathways 
leading to the formation of PGE products remained elusive before this thesis research 
was conducted.  Notably, PGE is not synonymous to HDR, but it specifically describes 
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the faction of HDR leading to the conversion of the desired knock-in mutations into the 
genome.  Because not all the HDR pathways have the same propensity of inducing gene 
conversions, retrospectively, the composition and hierarchy of the PGE pathways may 
be very different from the natural HDR. 
In this thesis research, I demonstrated that the meganuclease-induced PGE 
pathways in human cells are determined primarily by the types of homology donors and 
secondarily by the type and strandedness of genomic lesions (Figure 1).  dsDNA donors 
with a sizable heterology (>100bp) predominantly utilize the DSBR pathway both in the 
absence and presence of chromosomal DSBs, because it is the only long-tract gene 
conversion pathway that can efficiently convert large knock-in mutations without 
significantly sacrificing genomic stability.  This pathway generates bidirectional 
conversion tracts with a linear distribution (Figure 1, bottom left), which is centered at 
the central heterology being selected for during spontaneous PGE and at the 
chromosomal lesion during meganuclease-induced PGE.  The average conversion tracts 
are exactly half of the lengths of the effective homology arms.  Because we can simply 
increase the conversion tracts by using longer homology arms in the DSBR pathway, 
dsDNA donors are ideal for introducing large (multi-kilobase) mutations into the genome.  
The concept of dsDNA donors is not limited to linear and circular plasmids, but also 
applies to viruses with dsDNA PGE intermediates, such as adenoviruses and 
lentiviruses. Interestingly, I also prove that rAAV, as a single-strand DNA virus, becomes 
double-stranded during replication and serves as a type of dsDNA donor during 
spontaneous and meganuclease-induced PGE. 
In contrast, single-strand ODN donors utilize the SDSA and ssDI pathways, 
respectively, depending on the strandedness of the genomic lesion that initiates PGE 
(Figure 1, bottom right).  When the effective genomic lesion is complementary to the 
  141 
strand of the ODN donors, it initiates PGE via the SDSA pathway.  This pathway 
generates unidirectional conversion tracts with a Gaussian distribution that starts about a 
few bp upstream of the genomic lesions; on the other hand, when the effective genomic 
lesion is same to the strand of the ODN donors, it initiates PGE via the ssDI pathway.  
This pathway produces bidirectional conversion tracts with a Gaussian distribution that is 
slightly biased towards the upstream region of the genomic lesion.  Notably, both SDSA 
and ssDI are short-tract gene conversion pathways.  The effective conversion tracts are 
about 30 bp long with different directional biases with respect to the effective genomic 
lesion.  The Gaussian distribution of conversion tracts makes them extremely inefficient 
in converting large knock-in mutations used in dsDNA donors.  In the presence of 
double-strand genomic lesions such as DSBs and paired nicks, the lesion 
complementary to the strand of the ODNs is preferentially utilized to initiate the SDSA 
pathway, as long as the knock-in mutation on the ODNs is within the effective 
conversion zone of this pathway.  The ssDI pathway serves as a backup when SDSA 
fails to convert the knock-in mutation effectively. 
Collectively, this work determined the identity, property and hierarchy of the PGE 
pathways in human cells using definitive molecular evidence.  It did not only extend the 
paradigms of HDR-mediated gene conversion, but also established guidelines for the 
improvement of PGE:  
 
1. ODN donors can efficiently convert knock-in mutations up to 30 bp, whereas 
larger modifications have to be converted using dsDNA donors. 
2. dsDNA donors generate bidirectional conversion tracts with a linear distribution.  
Because of the mild drop-off on both direction of the curve, the knock-in 
mutations can be engineered into a wide range of regions (effective zones) as 
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long as there are enough flanking homology arms.  The highest efficiency is 
achieved when the mutation is right at the position of the genomic lesion. 
3. dsDNA donors mediate efficient PGE in the presence of DSBs and paired nicks, 
but not a single nick.  The half life of dsDNA donors in human cells is better 
correlated with Cas9/sgRNA expression in DNA format. 
4. ODN donors produce unidirectional and bidirectional conversion tracts with 
Gaussian distributions.  The steep drop-offs in the conversion tracts restrict the 
effective conversion regions to a <30 bp zone.  The predominant pathway and 
its conversion tracts have to be carefully considered to engineer the knock-in 
mutation into the effective zone. 
5. ODN-mediated PGE can be efficiently induced by all kinds of genomic lesions.  
The half life of ODN donors is better correlated with the RNA or RNP format of 
Cas9/sgRNA expression in vivo. 
6. Additional silent mutations have to be engineered to destroy the PAM 
sequence in the homology donors and prevent Cas9 from re-cutting the PGE 
products when PGE is induced by DSBs or paired nicks. 
7. The anti-recombination activity of the mismatch repair system represents the 
biggest barrier of PGE in human cells.  However, the level of suppression may 
vary in different PGE pathways depending on the length of heteroduplex DNA 
formed in the HDR intermediates.  This suppression can be alleviated by 
knocking down of the mismatch repair genes or using homology donors with 
locked nucleic acids [184, 185]. 
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Prospects 
At the end of this work, I would like to propose three bold predictions about the 
trends in genetics and genomics studies.  These predictions are not direct extrapolations 
from my current research, but the insights of the future genome engineering that I have 
drawn from more than 1500 publications in the field: 
The timeline of genome engineering 
Due to the unprecedented ease of genome engineering provided by the 
CRISPR/Cas9 technology, the timeline in generating genetically modified research 
models is infinitely approaching the life cycles of the specific organisms being used.  
Although the efficiency of genome engineering varies dramatically according to the DNA 
repair status of the specific organisms and the desired types of genomic modifications, 
multiplexed homozygous modifications can be routinely introduced in the F0 generation 
of the major model organisms [100-103], or within one round of genomic engineering in 
cultured human cells [167, 168].  Although the power of genome engineering has not 
penetrated every obscure model organism, transgenic mice with the desired genotypes 
can be generated within merely 4 weeks using embryo transfer [103], and in our hand, 
bi-allelic PGE can be achieved within 3 weeks in human cells.  The future development 
of this technique will dramatically increase the list of genome-tractable organisms, and 
obviate the need of sequential genome engineering, genetic crossing, drug selection and 
Cre recombination for complex genome modifications in these organisms. 
The shift of model organisms 
The extreme ease in genome engineering may lead to a shift of the subjects of 
biological research from lower to higher model organisms.  Historically, one of the 
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biggest reasons that lower model organisms were chosen for biological research was 
the existence of powerful tools to introduce desired genomic alterations via either 
forward or reverse genetics.  Although the fundamental biological processes may be 
conserved from lower these organisms to human beings, there is no denying that lower 
organisms are different from human beings in many aspects.  As a consequence, a 
significant amount of work has to be performed to verify the discoveries in the lower 
organisms before they can be extrapolated to human beings and make a realistic impact 
on human health.  With the advancement of genome engineering technique and the 
ever-increasing list of genome tractable organisms, nevertheless, introducing the desired 
genomic modifications will no longer be a bottleneck in the future biological research.  
Thus model organisms will be chosen mainly based on pertinence to important biological 
questions and relevance to human health.  It may lead to a dramatic shift of the subjects 
of biological research from lower organisms to higher models.  In the future, traditional 
model organisms such as yeasts, flies, worms and fish may play a decreasing role in 
biological research, whereas transgenic mammalian models such as mice, pigs and 
monkeys may be more frequently employed in studies closely related to human health. 
The flattening technology frontiers 
The unprecedented ease in genome engineering and the global sharing of 
plasmids between institutions or through non-profit organizations (such as Addgene) 
may lead to the gradual disappearance of technological barriers between laboratories.  
As the tools of genome engineering are becoming more and more convenient and user-
friendly, any scientists with basic laboratory trainings will be able to create the research 
models of the desired genotypes in the designated timeline of the published protocols.  
The edges between experienced laboratories and starters will become smaller and 
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smaller, and eventually technology will no longer become the bottleneck of future 
biological research.  One day, all laboratories will be starting at the same scratch line of 
the technology frontiers in the grand race of solving important biological questions.  As 
the technological barriers become lower, the bar of publications will continue to rise.  
The winners will be the ones that can timely identify and solve important biological 
questions and continuously push forward the knowledge and technology frontiers.  This 
will be the triumph of biology.  
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Figures and Legends 
 
Figure 1.  The hierarchy of meganuclease-induced HDR leading to PGE 
PGE is defined as the fraction of HDR leading to the conversion of the desired 
knock-in mutations using exogenous homology donors.  In the PGE products, 
retrospectively, the hierarchy of the HDR pathway is determined primarily by the types of 
homology donors and secondarily by the genomic lesions.  dsDNA donors containing a 
sizable central heterology must be converted via the DSBR model, which generates long 
conversion tracts with a linear distribution.  ODN donors can utilize both SDSA and ssDI 
pathways, depending on the strandedness of the ODNs and the relative position of the 
knock-in mutation to the genomic lesion.  These pathways generate short conversion 
tracts in normal distributions.  SDSA is preferentially utilized in the presence of 
compound genomic lesions when both pathways can convert the knock-in mutation 
effectively.  
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Figure 1 
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